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6SUMMARY
Since the isolation of neomycin from Streptomyces
fradiae by Waksman and Lechevalier in 1949, neomycin
has been successfully in treating infection caused by
gram-negative bacteria. Beside the therapeutic
significance, the aminoglycoside is also well known of
its ototoxicity, nephrotoxicity, neuromuscular blockade
effect and modulation of the normal function of several
excitable tissues (Schtbeci and Schacht, 1977 Schacht,
1986 Hawkins, 1976 and Baumann, Hamann and
Leung,1988). Recently, streptomycin has been used
successfully in the treatment of idiopathic trigeminal
neuralgia (Sokolovic, Todorovic, Stajeic and Petrovic
1986). From the works of the above authors, the
aminoglycoside may act diversely on cellular
mechanisms. The aim of the present study is to
investigate the possible effects of neomycin on the
conduction in nerve fibres.
Frog sciatic nerve and rat ventrolateral tail
-nerve were used to investigate the effect of acute
exposure- of neomycin on nervous conduction. In vitro
study of the A compound action potential was performed
in frog sciatic nerve. Amplitudes as well as the
conduction velocities were measured. There were no
statistically significant difference in change of
amplitudes and conduction velocities before and after
7the application of neomycin solution. In the present
experimental set-up, blocking effect of the A potential
of the frog sciatic nerve was shown with the
application of 20 mM KCL in isotonic ringer solution.
In vivo study of A C compound action potential were
carried out in the rat ventrolateral tail nerve. In
the A compound action potential, there were no
statistically significant difference in change of
amplitudes and conduction velocities before and after
the application of neomycin in Krebs solution. In the
C compound action potential, there were no
statistically significant difference in changes of
amplitudes and conduction velocities before and after
the application of neomycin in Krebs solution.
In the present experimental arrangement, 10 mM
K2SO4 in Krebs solution shows a complete blockade of
the A potential in 5-10 minutes. In the unmyelineated
nerve fibre, the blocking effect of the C potential is
slower and smaller than the myelinated nerve fibre.
The results from the present study indicate that
with the present experiment arrangement, neomycin does
not produce any acute functional impairment of nerve
conduction in the myelinated and unmyelinated nerve
fibres, even in the present of a fairly high
concentration (3500 mg/1). It is concluded that the
8action of neomycin on the nerve fibre behave
differently to that on the neuromuscular junction,
lateral line organ and Merkel cell 'receptor.
1INTRODUCTION:-
Neomycin belongs to the aminoglycoside group of
antibiotics. It is distinct from others by having three
sugar rings rather than 2, one of them being the
pentose ribose (ring III). It is produced by
Streptomyces fradiae and was first isolated in 1949
(Waksman and Lechevalier, 1949). The group is used
primarily to treat infection caused by gram negative
bacteria. Aminoglycosides can act to interfere with
protein synthesis in susceptible microorganisms
(Pestka, 1971 Sande and Mandell, 1985), changes in
cell permeability and transport (Hancock, 1981) or
misreading of the genetic code (Pestka, 1971). Besides
these therapeutic effect, the toxicity of the
aminoglycosides include neuromuscular blockade
(Adams and Matthew, 1973 Singh, Harvey and Marshall,
1978 Rosayro and Healy, 1978 Fickers,1983),
nephrotoxicity (Schtbeci and Schacht, 1977),
ototoxicity (Hawkins, 1976) as well as reduction of
responsiveness in touch corpuscles (Baumann, Hamann and
Leung, 1986). Recently, streptomycin had been shown
successfully in the treatment of idiopathic neuralgia
(Sokolovic, Todorovic, Stajeic and Petrovic, 1986).
The polyphosphoinositides were first isolated from
brain by Folch in 1949. They are synthesized by
sequential kinase reaction from phosphatidylinositol
and catabolized either to phosphatidylinositol by
2monoesteric cleavage of the phosphate groups or to
diglyceride and the respective inositol phosphates by a
phosphodiesterase. It plays an important role in signal
transduction from the receptors at the plasma membrane.
The link between inositol lipids and calcium signalling
was first recognized by Michell who noticed that all
agonists that seemed to use calcium as an internal
signal were also capable of stimulating the hydrolysis
of inositol lipids (Michell, 1975).
It has been suggested that the lack of inositol
and resulting metabolic disturbances are responsible
for the nerve conduction defects in diabetes (Winegrad
1983). The concentration of free inositol is reduced in
sciatic nerve of streptozotocin-diabetic rats (Greene,
De Jesus and Winegrad, 1975 Palmano, Whiting and
Hawthorne, 1977) and in post-mortem nerve samples from
diabetic patients (Mayhem, Gillon and Hawthorne, 1983).
Whether these changes account for the nerve conduction
defect of diabetes need further studies.
There is clear evidence of calcium fluxes as well
as the well known sodium and potassium fluxes
associated with the action potential in nerve
potential. Is the polyphosphoinositides metabolism
involved in the permeability changes accompanying nerve
impulse? Little is known about this possible mechanism.
3Neomycin has been used as a-tool to study the
polyphosphoinositide metabolism (Schacht, Weiner
Lodhi 1978). It has been shown to inhibit
phosphoinositide turnover in a number of tissues by
directly binding to phosphatidylinositol 4,5
bisphosphate (PIP2) and phosphatidylinositol 4-
phosphate (PIP) (Schacht 1976, Lodhi, Weiner and
Schacht, 1979). At low concentration, neomycin
selectively binds to PIP2 over PIP (Lodhi et al.,
1979).
Despite the modulating effect of the
aminoglycoside on many of the excitable tissues, little
knowledge is available in its action on the nervous
conduction in peripheral nerve. Neomycin is employed in
the present study to investigate whether acute exposure
to neomycin would affect the nerve conduction in
peripheral nerve.
SECTION I:- LITERATURE REVIEW
4SECTION I: LITERATURE REVIEW
. Structure of peripheral myelinated nerve fibres
Peripheral myelinated axons are elongated cell
processes derived from neuronal cell bodies in the
spinal cord or brain stem motor nuclei, in the spiral
and cranial sensory ganglia and in the autonomic
ganglia. The myelinated axons are surrounded by the
tubular myelin sheath which extends from a point near
the cell body excluding the initial segments and ends at
about 1 to 2 um from the axon terminals. The myelin
sheath consists of a series of cylindrical segments each
being termed an internode and derived from an individual
Schwann cell. The junction between successive Schwann
cells are called the nodes of Ranvier.
The Axon
Axolemma
The axon is bounded by a surface membrane, the
axolemma. On electronmicroscopic studies, it is an
asymmetric trilaminar membrane 7 to 8 nm in thickness.
The inner leaflet-is more osmiophilic and slightly
thicker than the outer and the leaflets are separated by
a clear zone (Elfvin, 1961 1963).
Axoplasm
5The axoplasm is the fluid cytoplasmic material
inside the axon. Inside there is a variety of
filamentous structures and organelles. Fixed silver-
stained-preparations of peripheral axons viewed by light
microscopy show longitudinally oriented fibrillar
material (Beer, Schmitt and Young, 1937). Electron
microscopy subsequently established the presence of
microtubules (neurotubules) and neurofilaments. The
microtubules are elements of the cytoskeleton of the
axon and probably involved in axonal transport
mechanisms. This structure is cyclindrical in appearance
with a diameter of average 25 nm and a wall of 5 nm in
thickness surrounding a hollow core, sometimes
containing 5 nm granules. They are occasionally
interconnected to neighbouring organelles such as
mitochrondia or neurofilaments. The axonal microtubules
are more marked in the region where the neurofilament
density is reduced and may be associated with
mitochondria and cisternal of smooth endoplasmic
reticulum (Raine, Ghetti and Shelanski, 1971). The
neurofilaments are unbranched longitudinally oriented
structures with an average diameter of 10 nm and
uncertain length (Wuerker and Kirk, 1972). Their
function is not understood adequately. They may be
involved in axonal transport mechanism.
The mitochondria originate from the cell body and
are then slowly translocated down the axon. Time-lapse
6photography of living amphibian axons shows rod-like
particles that are probably mitochondria, which exhibit
jerky movements. in either direction or move slowly in an
antero-grade direction at a rate of 1.5 mm/day (Cooper
and Smith 1974). The mitochondria are more numerous in
small axons (ranging from 2 to 5 /um) than in larger
axons (average 0..1 um).
The axonal smooth endoplasmic reticulum is seen as
discrete tubular or flattened cisternae in transverse or
longitudinal section. It is a continuous reticular
meshwork extending from the axon hillock to the nerve
terminals and are occasionally expanded in the form of
flattened subaxolemmal plates. (Droz, Rambourg and
Koenig, 1975).
The periaxonal space is a space between external
aspect of the axolemma and the plasmalemma of adaxonal
Schwann cell. It occupies a space of about 15 to 20 nm.
It may be arranged in 5 or 7 layered configuration with
a 2 to 4 nm intramembranous space.
Schwann cell
The Schwann cell can be considered as a flattened,
trapezoid-shaped cell that is wrapped spirally around
the axon. It can be divided into three portions. The
adaxonal cytoplasmic margin constitutes the innermost
portion while the ab-axonal cytoplasm or outer belt
that surrounds the myelin sheath and bears the nodal
7microvilli at its margin in the outer portion. The
intermediate part constitutes the compact myelin, the
lateral cytoplasmic rim of which has a helical
attachment to the axolemma a-at the paranode. The myelin
is traversed by cytoplasmic channels, the incisures of
Schmidt-Lantermann, most of which interconnect the
adaxonal and abaxonal cytoplasm. The adaxonal Schwamm
cell cytoplasm runs in a spiral manner that executes
slightly more than one complete turn. At the region of
overlap, the apposition of the adjacent surface
membranes is termed the mesaxon. The amount of abaxonal
cytoplasm is frequently limited, the surface membrane of
the Schwann cell closely overlying the outermost myelin
lamella. It again consists of a spiral process.
The myelin sheath
The myelin sheath is a membrane system which is
characterized by highly regular construction composed of
spirally arranged lamellae. Each individual lamella
arises by the spiral wrapping of Schwann cell
plasmalemma around that axon during myelination. From
the polarization optical findings on the myelin sheath
and with the results of X-ray diffraction studies
(Schmitt and Clark, 1935), the myelin sheath consists of
alternating cylindrical layers of lipid and protein. In
this. arrangement, the lipid forms a bimolecular leaflet
oriented with the hydrophobic ends directed toward the
8center and with the hydrophilic polar ends extended
outward and sandwiched between monolayers of protein.
This concept of the myelin sheath configuration was
supported by ontogenetic studies of myelin in chick
embryo (Geren, 1954) and high resolution electron
microscopic analyses (Robertson, 1955).
The Node of Ranvier
In 1871, Ranvier observed that the myelin sheath
was indented at regular intervals. The essential feature
of the nodes was a complete interruption of the myelin.
The terminal part of the myelin approaches the nodal
axon at an acute angle. in the smaller fibres while on
the larger fibers, the ends of the myelin segments form
bulbous expansions and the terminal myelin approaches
the axon more steeply, sometimes being recurved so that
it forms an angle in excess of 900.
The part of the axon which is exposed at the node
of Ranvier i.e. the nodal axon, is narrowed. The
relative degree being greater for the larger fibers.
The paranodal region
The terminal cytoplasmic rim of the myelin lamellae
is firmly adherent to the axolemma at either side of the
node. The axolemma at the junction with the helical rim
9is specialized. This portion of the axon is designated
the paranodal region and-, separates the nodal and
internodal portions of the axon. Fracture faces through
the paranodal region disclose a helical ridge and trough
pattern conforming to the apposition of the Schwann cell
terminal cytoplasmic helix( Schnapp and Mugnaini,1978).
The'paranodal apparatus may be involved in impulse
generation. It seems that the area of the exposed nodal
axolemma is insufficient to accommodate the number of
sodium channels found from saxitoxin binding experiments
(Wiley and Ellisman, 1980) and it was proposed that the
exchanges of sodium at the nodes utilize a synaptic
junction in the paranodal region. Ellisman and co-
workers found an elevated concentration of sodium in the
helical cytoplasmic rim of Schwann cell in the paranode
(Ellisman, Freedman and Hamilton, 1980). They postulated
that this portion of the Schwann cell provides the
source for the inward flux of sodium ions that occurs
through the nodal axolemma during generation of the
action potential. The sodium is then pumped out by the
nodal axolemma and taken up from the nodal gap by the
Schwamm cell nodal microvilli from where it moves to the
paranodal cytoplasmic helix.
Unmyelinated nerve fibre
In mammals, there are approximately 75%
unmyelinated axons in cutaneous nerves and dorsal spinal
10
roots (Ochoa and Mair, 1969), 50% in muscle nerves and
30% in ventral roots (Coggeshall, Coulter and Willis,
1973 1974). White rami communicantes contain
approximately two-third unmyelinated axons (Coggeshall,
Hancock and Applebaum, 1976).
The axoplasm
The axoplasm of unmyelinated axons is qualitatively
similar to that of myelinated axons and also to that of
immature axons. The concentration of neurofilaments is
comparable but that for microtubules is greater than the
myelinated axons (Berthold, 1978). Elongated
mitochondria and dense cored vesicles occur but not
abundant in unmyelinated axons (Ochoa, 1976).
The schwann cell
The satellite cells associated with unmyelinated
axons and those associated with myelinated axons have a
common embryological origin. Their structural features
show many similarities. The nuclei of satellite cells
associated with unmyelinated axons are elongated and
smooth in contour, aligned longitudinally like a series
of bacilli and possess one or more nucleoli. The
cytoplasm of the satellite cells contain a variety of
organelles in the perinuclear region while elsewhere in
the cytoplasm only occasional filaments, microtubules
and sparse mitochrondia. Elements of the golgi complex
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are consistently found near the nucleus of Schwann
cells. (Ochoa, 1976).
The whole surface of unmyelinated axons in normal
mature somatic nerves is invested by Schwann cell
process. When a Schwann cell process fails to cover part
of the surface of a peripheral axon, there is still a
layer of basal lamina separating the axon from the
endoneurium. Short isolated Schwann cell processes
located externally within the axonal-Schwann cell
complexes are the collegan pockets. This term was
described by Gamble and Eames (1964) in peripheral
nerves of rats and human and are exclusive features of
unmyelinated fibres (Gamble, 1964)
1.2 Relationship between myelin thickness and axon
diameter
Studies on the consequences of cross anastomosis
between myelinated and unmyelinated nerves indicate that
it is the axon that provides the stimulus for the
Schwann cell to produce myelin (Hillarp and Olivecroma,
1946). There are controversial reports related to myelin
thickness against axon diameter. Sanders (1948) found
that there is a linear relationship between myelin
thickness and axon diameter. Other workers have found
either a direct rectilinear correlation between myelin
thickness and axon diameter (Williams and Wendell-Smith,
12
1971) or a relatively greater myelin thickness for
fibres of smaller diameter (Evans and Vizoso, 1951). on
the other hand, Buchthal and Rosenfalck (1966) found
that myelin thickness was proportionally greater in
larger fibres. The ratio (g) between the total fiber
diameter and axon diameter derived by Schmitt and Bear
in 1937 had been found useful in theoretical treatment
relating to saltatory conduction. Rushton (1951)
predicted that a value of 0.6 to 0.7 for g would be
optimal for conduction velocity and was subsequently
reiterated by Hodgkin in 1967 and Smith and Koles in a
computer simulation in 1970).
1.3 Classification of nerve fibres in peripheral nerve
The existing classification of nerve fibres in
peripheral nerves are based either on the conduction
velocities or on fibre diameters. In the studies of
electrical stimulation of frog sciatic nerve, Erlanger
and Gasser (1937) used A plus Greek letters alpha, beta,
gamma, delta to identify successive peaks of the action
potential in order of decreasing conduction velocities.
Subsequently, two additional peaks produced by fibres of
much lower conduction velocity were discovered and were
called B and C fibres. The A potential are produced by
myelinated fibres ranging from large to small diameters,
In mammalian nerves the B wave are considered to be
action potential of the preganglionic (small diameter
myelinated) fibers in autonomic nerves. In peripheral
13
nerve, the A delta is applied to the B conduction
velocity in the sympathetic fibers. The C-potential is
produced by the unmyelinated fibers (Erlanger and
Gasser, 1937 Keynes, 1972).
An alternative classification for afferent nerve
fibres was based on the fibre diameter (Llyod, 1943).
Based on the distribution of fibre diameters, there are
4 different fibre groups (range from Group I to IV) in
somatic nerves. The fibres diameter and their
corresponding level with the Erlanger and Gasser
classification is as follow:
Diameterconduction velmuscleCutaneous nerve
in catnerve





(From Light and Perl, (1984) in Peripheral Neuropathy
pp. 213).
These two classifications have lead to
confusion and controversy on how to use them. Some
workers use Llyods (1943) classification to all afferent
14
fibres and Erlanger and Gasser's (1937) classification
for the efferent fibres( Jaenig and Zimmermann, 1971
Bowsher, 1970). Thus afferent fibres from muscles were
subdivided into its Group I, II, III by Llyod's
system. Cutaneous afferent myelinated fibres fall into 2
groups namely II and III since the mean diameter of the
large cutaneous afferents is considerably less than that
of Group I muscles afferent. These 2 groups of fibres
correspond to the A alpha and A gamma as dervied by
Gasser's classification. However, the initial peak
called A alpha by Gasser was called A beta by Erlanger
because its conduction velocity was like that of the A
beta peak in muscle nerve. The unmyelinated fibres
produce with later peak called C and was correspond to
Group IV fibre by the Llyod classification.
1.4 Relationship between fiber diameter and conduction
velocity
Gasser and Grundfest (1939) studied the compound
action potentials in isolated cat saphenous nerves which
were subsequently fixed for light microscopy. They, like
Hursh (1939) in his slightly earlier work from the same
laboratory, concluded that a scaling factor of 6 was
appropriate for large cutaneous afferent fibres. The
scaling factor for alpha-efferent fibres was found to be
5.7 in de-afferentated muscle nerves in the cat by Boyd
(1964) and the scaling factor for all sizes of gamma-
15
efferent fibre is 4.5 (Boyd, 1964 Boyd and Davey, 1968
Boyd and Kalu, 1979).
II.ACTION POTENTIAL
Resting membrane potential
In 1902 Bernstein suggested that the resting
membrane was selectively permeable to K+ and that the
potential differences across it arose from the tendency
of K+ to move outwards from the more concentrated
solution inside a nerve or muscle fibre. Thus if a
membrane which is selectively permeable to K+ separates
axoplasm containing 400 mM K+ from plasma containing 20
mM K+, one would expect the inside of the membrane to
be 75 mV negative to the external solution. This value
is obtained from the Nernst equation adopted for
potasssium:
Vk= RT/ZF (in [K]0/[K])
where Vk=equ1i1brium potential of the potassium ion
potential.
[K]o and [K]i are the K+ concentration outside and
inside the fibre. This hypothesis has been substantited
by (Keynes and Hodgkin, 1953) in undissected squid axon
defined in the sense,internal potential minus external
16
with natural circulation, resting membrane potentials of
about 70 mV was observed.
2.1 Activation of nervous impulse
Action potentials in peripheral nerve fibre are all
or none in amplitude. Action potential can only be
elicited when a depolarizing current has reached a
certain value, i.e. its threshold. When the depolarizing
current changes the resting potential from -60 my to
about -45 mv, an action potential is elicited. A simple
way of explaining the reversal of the membrane potential
is to assume that when the membrane is activated by an
electric current it momentarily becomes selectively
permeable to sodium ions. In support of this idea, it is
found that the action potential of many but not all
excitable tissues disappear in the absence of external
sodium or lithium ions. The state of increased sodium
conductance wears off after about 1 msec. and the
potential therefore tends to return to its original
level. The process of repolarization is greatly
accelerated by the fact that depolarization causes a
delayed rise in the conductance to potassium ions. This
speeds up the exit of-potassium ions and keeps the whole
action potential reasonably short.
The conductance for potassium ion rises and the state
of increased potassium ions conductance persists for
c-PVPra1 msec. Thus the membrane potential approaches
17
more closely to, the potassium equilibrium potential with
the result that the fibre undergoes a transient phase of
hyperpolarization. Evidence for this suggestion is
provided by the observation that the membrane potential
during the underswing is affected by potassium
concentration which have relatively little effect on the
resting membrane potential (Hodgkin and Katz, 1949
Hodgkin and Keynes, 1955b Frankenhaeuser and Hodgkin,
1956). The resting potential disappears if the external
potassium concentration is made equal to the internal
concentration and that except at low external
concentration of potassium, the potential varies in the
manner predicted by the Nernst equation.(Adrian, 1956
Hodgkin and Keynes, 1955b).
2.2 Sequence of event during the action potential, the
Voltage clamp method
The development of voltage-clamp method by Cole and
Marmont in 1949 facilitated the studies on the
electrical properties of the membrane to be more
quantitative. In this method, the membrane potential is
suddenly displaced from its resting value and held at a
fixed.. potential by a feedback amplifier. The current
which flows through a definite area of membrane under
the influence of the imposed voltage is measured with a
separate amplifier.
18
When the resting potential of the fibre was raised
suddenly by 65 mV. by applying a rectangular pulse to
the feedback amplifier which control the membrane
potential, the sodium conductance increases greatly and
rapidly and result in the movement of sodium ions from
the highly concentrated exterior to the interior of
cell. When the external solution is made sodium free
with the- substitution of choline, the inward current
pulse is eliminated, thus verifying the inward current
is caused by the sodium entry (Hodkgin and Huxley,
1952a).
If the concentration of sodium ion is kept at its
normal value and the amplitude of the voltage step is
gradually increased, at a certain value, 117 mV in
Hodgkin's experiment (Hodgkin et al, 1952), the initial
hump of the current disappears. If the early hump of
current is carried by sodium ions, the equilibrium
potential, at which there is no sodium current, should
be given by the Nernst equation:
VNa= RT/ZF (ln [Na] o/ [Na] i)
Where VNa is the equilibrium potential of the sodium
ion.
[Na]o and [Na]i is the sodium concentration outside
and inside the fibre.
19
The results hold to within about 1 mV over a ten-
fold range of [Na]o (Hodgkin and Huxley, 1952).
The sodium current starts to decline at about 0.5
ms and the main current becomes an outward potassium
current. This current is uncomplicated by sodium current
if the membrane potential during the voltage step is
made equal to VNa and this current is not much altered
if sodium ions are replaced by choline and is also
present in chloride deficient solution. Futher evidences
of the outward potassium current include 1. radioactive
tracer studies by Hodgkin and Huxley (Hodgkin and
Huxley, 1953). 2. the equilibrium potential of the
second component varies with the external potassium
concentration (Frankenhauser and Hodgkin, 1956).
2.3 Hodgkin= Huxley formulation
The sodium or potassium permeability of a membrane
can be expressed in terms of conductance parameters gNa
and gK defined as:
gNa= INa/ (V- VNa)•
9K= IK/ (V- VK).
Where V is the transmembrane potential
VNa and VK are the Nernst potentials of sodium and
20
potassium ions respectively.
INa and IK are the currents per unit area carried
by the sodium and potassium ions.
Therefore, the instantaneous value of the current
INa or IK is directly proportional to the driving force,
V- VNa or V- VK.
The rate constants governing the turning on and off
of the sodium or potassium conductance depend on
temperature, membrane potential and calcium
concentration, but are little affected by changes in
sodium concentration, or by the direction of the ionic
current. (Hodgkin and Huxley, 1952 Frankenhaeuser and
Hodgkin, 1957).
A dynamic description of an action potential can be
formulated through the use of a membrane model that
includes parameters as sodium and potassium
conductances, their respective Nernst potential and the
membrane capacitance.
The complete expression for the membrane current
density I is:
I c dV /dt+ (V- VK) gK n4+ (V- VNa) gNa m3 h+ (V
VL) gL
Where c= specific membrane capacity per uiii t. a.Lca.
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9K is the maximum potassium conductance.
n is the probability that a single particle is in
the right place.
gNa is the maximum soaium conauczance.
m3 h= probability that there will be three
activating particles and no blocking particle.
gL= leak conductance.
Relating the current density in a nerve fibre
surrounded by a large volume of external fluid is:
I= a/ 2R dV /dX2
Where a= the radius of the axoplasm and R is its
resistivity. X is the distance along the nerve. In the
case of a fibre propagating at constant velocity (0), X
may be replaced by -Ot
Hence:
a/2 R02 d2 V/dt2= c dv/dt+ (V -Vk) gK4 N+(V- VNa) gNa
m3 h+ (V- VL) qL
Impulse propagation
22
Solution of the Hodgkin- Huxley equation gives the
components of membrane conductance during propagated
action potential as shown on diagram 1.
The equilibrium potentials of the sodium and
potassium ions are represented by the 2 horizontal line.
The broken curve gives the membrane potential and the 2
solid curves are the sodium and potassium conductances.
At rest, the membrane potential is fairly close to the
equilibrium potential of the potassium ion. As the
impulse advances, the membrane just ahead of the active
regions becomes depolarized by electric currents flowing
in a local circuit through the axoplasm and external
fluid. The sodium ions enter the fibre owing to the
change in membrane potential and rise of sodium
conductances. This inward currents make the inside of
the fibre positive and provides the current required to
depolarize the resting membrane ahead of the active
region. At the crest of the spike, the sodium
conductance declines and the potassium conductance rises
so that the rate of potassium ions leaving the fibre
exceeds that of sodium ions enter the fibre. The slow
effects of depolarization namely raised potassium
conductance and inactivation of the sodium carrying
system, persist for a few milliseconds after the spike
and gives rise to the refractory period. This refractory
period can be divided 'into absolute and relative














Dia.g.-rem 1 Theoretical action potential and conductance changos obtained by numerical
solution of equation and subsidiary equations for n, m and h the constants used were
appropriate to a temperature of 18.6°C from Hodgkin Huxley (1952). Total entry




caused by the opening of the potassium channels and the
inactivation of sodium channels. The residual opening of
active potassium channels leads to a greater efflux of
potassium from the cell than occurs in the resting
state. This efflux causes. the membrane potential to
hyperpolarize slightly with respect to its normal
resting value.
2.4 Extrusion of the sodium ions= sodium pump mechanism
The efflux of the sodium ions can be studied by
radioactive tracer method( Hodgkin Keynes 1955a) in
which the nerve fibres were loaded with radioactive
sodium ions by stimulation in a solution containing this
isotope. The subsequent wash out of this radioactive
isotope was collected and measured. In this way, one can
study the fate of the sodium ions which enter during
activity and are subsequently ejected by the action of a
metabolic pump. The energy requirement of the sodium
pumping mechanism was confirmed by Hodgkin and Keynes
1955. In their study, dinitrophenol, an metabolic
inhibitor was added to a Sepia nerve fibre, the sodium
efflux was reduced to about 1/20 of its normal value,
the inhibitory effect takes place with a time constant
of 15--to 30 minutes and is largely but not completely
reversed by washing the dinitrophenol away. Cyanide (1
to 10 mM) and azide (3 mM) have essentially the same
action as dinitrophenol on the outflow of sodium.
Caldwell (1956) showed that the immediate source of
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energy for the pump is by the dephosphorylation of the
ATP and that'the arginine phosphate acts by replenishing
the ATP. Caldwell and Keynes (1957) calculated that
about 4 phosphate bonds are broken for each sodium ion
expelled. Thus the sodium efflux system is an active
process which is energy dependent.
Reabsorption of potassium ions
It was well established that the outflow of
sodium and the uptake of potassium depend on metabolism,
and the two movement are coupled in a cyclical mechanism
(Hodgkin and Keynes, 1955a). Evidence for a coupling
between sodium efflux and potassium influx has been
obtained in muscle( Keynes, 1954), red cells (Glynn,.
1956) and frog skin (Ussing, 1954).
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III.AMINOGLYCOSIDE
3.1 Structure of Aminoglycosides
The aminoglycoside group of antibiotics includes
a large number of structurally related polycationic
compounds containing two or more amino sugars connected
by glycosidic linkage to a hexose core. The group
consists of streptomycin,. neomycin, kanamycin,
tobramycin and paromomycin which are derived from
different species of Streptomyces gentamicin,
netilmicin and sisomicin which are derived from
micromonosporum species, Amikacin is produced through
chemical modification of kanamycin (Umezawa, 1974).
Neomycin, kanamycin, gentamicin and tobramycin
constitute a group distinct from streptomycin. They all
contain the base deoxystreptamine linked to various
aminohexoses. Streptomycin contains streptidine,
neomycin is distinct from others by having three sugar
rings rather than two, one of them being the pentose
ribose (ring III). It is produced by streptomyces
fradiae and was first isolated in 1949 (Waksman and
Lechevalier, 1949).
The group are used primarily to treat infection
caused by gram negative bacteria. They can act to
interfere. with protein synthesis in susceptible
microorganisms (Pestka, 1971 Sande and Mandell, 1985),
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change in cell permeability and transport (Hancock,
1981), or misreading of the genetic code (Pestka, 1971).
There are clear differences in the way the various
aminoglycosides interact with the protein.synthetic
machinery at the molecular level. However, the rapid
lethal effect can not be explained by the above factors.
Schacht (1974, 1976) found that neomycin affects the
lipids of the cell membrane instead of inhibiting
protein synthesis. Bryan (1984) suggested that the
progressive disruption of the cell envelope may explain
the lethal action of aminoglycoside antibiotics.
3.2 Antibacterial activity of the aminoglycosides
The aminoglycosides are potent gram negative
antimicrobial drugs, kanamycin and gentamicin,
tobramycin and amikacin are used most commonly to treat
infection caused by aerobic gram negative bacilli. In
vitro studies, activity of aminoglycosides are strongly
dependent on the cation content and pH of the growth
medium. It is because these factors modify the ability
of bacteria to actively take up the drugs (Hancock,
1981). Anaerobic bacteria are not susceptible to
aminoglycosides because active uptake of these drugs by
the bacterium requires respiration (Hancock, 1981).
3.3 Pharmacology of the Aminoglycoside antibiotics
3.3.1 Absorption
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Aminog.lycosides pass across membranes very
poorly and only about 1% of an orally administered dose
are absorbed from the gastrointestinal tract (Kunin et
al., 1960). Aminoglycosides (principally neomycin and
kanamycin)-- are administered orally to kill the bowl
flora before intestinal surgery. Since there is
essentially no absorption, this constitutes local
administration of the drug. The aminoglycosides (except
for neomycin) are routinely administered by
intramuscular injection and peak blood level are
achieved in about one hour (Leroy, Humbert,
Oksunhendler and Fillastre, 1978 Neu, 1982 Ristuccia
and Cunha, 1982 and Brogard, Comte and Spach, 1984).
Aminoglycosides are presented in many antibiotics
formulation used in_topical therapy and wound irrigation
(MacDonald and' Beck 1983). Absorption through intact
skin is minimal but there may be significant absorption
if aminoglycosides are applied to burned area or open
wound.
3.3.2 Distribution
The aminoglycosides are largely excluded from most
cells-because of their polar nature. The volume of
distribution is equal to the extracellular fluid volume
(Sande and Mandell, 1985). There is little or no binding
of aminoglycosides to serum protiens (Gordon, Regamey
and Kirby, 1972). They accumulate to high levels in
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kidney where tissue concentration of amikacin and
gentamicin have been reported to vary form 16-89 times
the plasma concentration (Edwards, 1976). High
concentration of aminoglycoside is also found in the
endolymph and perilymph of the inner ear (Sande and
Mandell 1985).
3.3.3 Excretion
The aminoglycosides are excreted in their active
forms by glomerular filtration. Most of the
aminoglycosides are not metabolized. The half lives are
in the range of 2 to 3 hours (Barza and Scheife, 1977).
In anuric individual, the half lives range from 50 to
100 hours or more. The concentration associated with
toxicity is not-much greater than that required for
treatment of many bacterial infection.
3.4 Toxicity of the Aminoglycosides
3.4.1 Neuromuscular blockade
Vital-Brazil and Corrado in 1957 were the first to
report that streptomycin causes blockade of the
neuromuscular junction in the same way as does curare.
Kubikowski and Szrenawski (1963) showed the
neuromuscular junction was inhibited by kanamycin in
vivo experiment. Vital-Brazil and Prado-Franceschi
(1969) showed similar effect by gentamicin. Pittinger et
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al. (1970) mentioned in their clinical reports that
gentamicin and neomycin increased the anesthetic effect
of ether during. surgery and caused respiratory
paralysis. Neomycin has the blocking effect on the
neuromuscular junction in vitro using the nerve and
muscle preparation of mouse and rat diaphragm. (Adams
and Matthew, 1973 Singh, Harvey and Marshall, 1978
Rosayro and Healy, 1978).
The neuromuscular blocking properties of various
aminoglycosides antibiotics such as streptomycin and
neomycin have been explained (competitive hypothesis) on
the basis that these antibiotics compete with calcium
ions for the same receptor on the nerve terminal
membrane and produce complexes that are incapable of
transmitter release( Vital-Brazil and Prado-Franceschi,
1969 Yamada, Kuno and Iwanaga, 1986)
The neuromuscular blockade produced by the
aminoglycosides antibiotics streptomycin and kanamycin
and its reversal by calcium were quantitatively studied
in the isolated phrenic nerve diaphragm preparation of
the rat (Prado, Corrado and Marscillan, 1978). The
uptake of calcium with stimulation of the isolated
superior cervical ganglion was blocked by neomycin. It
decreased the calcium influx associated with the nerve
terminal action potential presumably by affecting the
voltage sensitivity of the calcium channel (Wright and
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Collier, 1977). The neuromuscular block produced by
aminoglycoside antibiotics was completely reversed by
either calcium ions, 4 aminopyridine or 3, 4
diaminopyridine( Enomoto and Maeno, 1981). McQuillen
and Engback (1973) noted that neomycin decreased the
probability of release of quanta of acetycholine but not
the size of the releaseable store. When administered to
cats for 22- 28 hours, the blockade produced by
neomycin came to resemble a curare-induced blockade (Lee
and DeSilva, 1979). In addition, postsynatic blocking
action of the aminoglycosides had been demonstrated
(Vital-Brazil and Corrado, 1957 Singh, Mashall and
Harvey, 1982). The postsynaptic effect of two
aminoglycoside antibiotics, streptomycin and neomycin
were studied on miniature end-plate currents and
acetylcholine induced end plate current fluctuations in
voltage clamped costo cutaneous muscle of the garter
snake. The results suggested that neomycin interacts
with the ionic channels of the acetycholine receptor in
their open configuration whereas stretpomycin acts
primarily by blocking the receptor( Fickers, 1983).
To summarize the available information, neomycin
may block neuromuscular junction by a prominent
depressant effect on the nerve terminal inhibiting




Hawkins (1976) defined ototoxicity as the tendency of
certain therapeutic agents and other chemical substances
to cause functional impairment and cellular degeneration
of the tissues of the inner ear, especially of the end
organs and nerves of the cochlear and vestibular
division of the VIIIth. cranial nerve.
The aminoglycosides are ototoxic to both the
hearing and balance- functions of the inner ear.
Streptomycin primarily affects the vestibular system.
Whereas neomycin, kanamycin and amikacin are primarily
toxic to the cochlea especially the organ of Corti and
Stria Vascularis (Stockhorst and Schacht, 1977). It has
been speculated that the pathogenesis of aminoglycoside
ototoxicity is related to the accumulation of the drug
in the inner ear fluids the more ototoxic the
aminoglycoside, the longer its retention in the
labyrinthine fluids (Federspil et al., 1976). However,
study by Tran Ba Huy and coworkers (1986) on the
kinetics of gentamacin uptake and release in various
organ of the rat show that the uptake of gentamicin by
the tissues of the inner ear is dose dependent. It
manifests rapid saturation kinetics and leads to a
distribution of the drug into different compartments.
There is no accumulation either in tissues or in
labyrinthine fluids and ototoxicity seems to be related
to the penetration of the drug into compartments from.,
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which the half-life of disappearance is extremely low
(Tran Ba Huy, Bernard and Schacht, 1986). Recent review
by Schacht (1986) stated that aminoglycosides do not
accumulate in inner-ear fluids and aminoglycoside level
in fluids do not correlate with the otoxic potential of
a drug and selective toxicity cannot be explained by
selective tissue penetration of the drugs.
The primary pathophysiological leison is
destruction of hair cells in the organ of Corti. Light
microscope observations of the ototoxic lesion produced
by the aminoglycosides antibiotics in the guinea pig
cochlea reveal a selective destruction of the end organ
sensory hair cells. At low doses, hair cells in the
basal turn of the cochlea are affected first, with
destruction progressing toward the apex as the
aminoglycoside dosage increased. Thus aminoglycoside
ototoxicity begins in the region where high frequency
sounds are processed and then extends to regions of
lower frequency (Brummett, Fox, Bendrick and Himes,
1978 Brummett, 1981).
The extent of the cochlear lesion is determined by
the dose and frequency of administration of the drugs
and may occur following a latent period after drug
treatment has stopped. On an equal-dose basis the
ototoxic liability of gentamicin was found to be similar
to that of sisomicin, whereas the ototoxic liability of
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tobramycin was found to be similar to that of amikacin.
Tobramycin and amikacin were less ototoxic than
gentamicin and sisomicin (Brummett et al., 1978).
The mechanism of the ototoxic action is not well
established. The aminoglycosides do not readily pass
across cell membranes and it seems likely that at least
the rapid and reversible toxicity may result from an
interaction of the drug with superficial membrane
structure. Physical studies of neomycin interaction with
synaptosome membranes and synthetic lipid monolayers
show that physical distortion of membranes occurs at
high drug concentration (Lodhi, Weiner and Schact, 1976
1977). Other probable mechanism includes:
1. Aminoglycosides may have a direct plugging effect on
the transduction channels in hair cells. The strong
cationic functional groups on the aminoglycosides might
enter the transduction channel and block it by
plugging. The blockage is voltage dependent, the
reduction of the current become larger with
hyperpolarization of the membrane. This has been
demonstrated by Ohmori in isolated vestibular hair cells
of the chick. (Ohmori, 1985).
2. Aminoglycosides may disturb the normal ionic balance
of the endolymph. The disturbance of the normal ionic
concentration in the labyrinthine fluid may lead to
impairment of electrical activity and nerve conduction.
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(Neu and Bendush,. 19 7 6).
3. Aminoglycoside may compete with calcium ions for
binding sites on membranes necessary for -transduction.
By increasing calcium concentration in the fluid bathing
the apices of hair cells, the effects of aminoglycoside
were counteracted (Kroese and Van den Bercken, 1980
Williams, Zenner and Schacht, 1987).
4. Inhibition of ornithine decarbosylase (ODC) activity
by the action of neomycin. Neomycin produced a dose-
dependent inhibition of ODC with half maximal inhibition
observed at 50 uM and almost complete inhibition at
100uM (Henly, Gerhardt and Schacht, 1987).
3.4.3 Relationship between binding of aminoglycosides to
polyphosphoinositides and ototoxicity
Schacht (1974, 1976, 1986) found that neomycin
affected the lipids of the cell membrane. He also
demonstrated a high rate of polyphosphoinositide
metabolism in the inner ear. Perfusion of guinea pig
cochlea with artificial perilymph containing a high
concentration of neomycin causes a rapid reduction in
its ability to generate an acoustic current potential in
response to a sound stimulus (Nuttall, 1977). Neomycin
have been shown to competitively inhibit the binding of
radioactive calcium ion to homogenised tissues and to
nhncnhninncitideS in artificial tissues (Schacht, 1976).
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The suppression effect can be reversed by the
application of excess calcium (Sand, 1975 Yanagisawa et
al., 1977). Binding of aminoglycosides to
phosphatidylinositol has- also been demonstrated
Yanagisawa et al., 1984 and Schact, 1986). Neomycin
occupies calcium binding sites provided by negatively
charged phosphate groups of the polyphosphoinositides in
the membrane. The neomycin-bound phosphoinositide is a
poor substrate for the dephosphorylating enzyme and the
dephosphorylating enzyme and the dephosphorylation
phosphorylation cycle is disturbed (Schacht, 1976).
3.4.4 Nephrotoxicity
The aminoglycoside specifically damage the
epithelial cells of the renal proximal tubules. This
toxic action involves three steps. The uptake of the
antibiotics into the cells, the intralysosomal lipid
storage and finally cell necrosis. Neomycin is the most
nephrotoxic aminoglycoside and streptomycin is the least
nephrotoxic. It has been shown that neomycin binds to
polyphosphoinositides and inhibits their
dephosphorylation in the rat kidney in the same way as
in the hair cell (Schtbeci and Schacht, 1977). Recently
Hagiwara and his co-worker had shown that the
nephrotoxity action of the. aminoglycoside takes place
by selective inhibition of intracellular protein kinase
C which is due to the positive charge contributed by the
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amino groups (Hagiwara, Inagaki, Kanamura, Ohta and
Hidaka, 1988).
3.4.5 Effects of neomycin on slowly adapting type I
(s.a.I) cutaneous mechanoreceptor
Neomycin was found to strongly suppress the
excitability of slowly adapting type I (s.a.I) cutaneous
mechanoreceptor. A dose of 12.5 mg. of neomycin in 5 min
was found to cause strong depression in responsiveness
of s.a.I receptors in cat (Baumann, Hamann and Leung
1986). Chronic neomycin injection was found to cause
alteration of the mechanical properties of the skin as
well as the responsiveness of the s.a.I cutaneous
mechanoreceptors in rat. One of the probable mechanism
is neomycin may exert its effect on s.a.I receptors by
interacting with phosphatidylinositol bisphosphate and
inhibit the generation of inositol trisphosphate which
had been demonstrated in the hair cells(Baumann et
al., 1986 Leung 1986).
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VI. POLYPHOSPHOINOSITIDES IN EXCITABLE CELLS
Introduction
The mechanism by which the 'message' generated at
the receptor is transferred to the inside of the cell
can be divided into 2 classes. One class of receptors
mediates its response through formation of cAMP,
catalyzed by adenylate cyclase (a protein present on the
cytoplasmic side of the membrane). The coupling of
adenylate cyclase *to the receptor is further regulated
by GTP-binding proteins. Another class of receptors
mediate its response through calcium mobilization.
Evidence is rapidly indicating that a specific class of
phospholipids i.e. the phosphoinositides plays an
important role in signal transduction from the receptors
at the plasma membrane. The link between inositol lipids.
and calcium signaling was first recognized by Michell in
1975 (Michell, 1975) who noticed that all agonists that
seemed to use calcium as an internal signal were also
capable of stimulating the hydrolysis of inositol
lipids. Detailed biochemcial studies had revealed that
agonists seemed to act preferentially to hydrolyze
phosphatidylinositol -4,5-bisphosphate (PIP2) to yield
.inositol 1,4,5 trisphosphate (IP3) and diacylglycerol
(DG). These two products appear to function as second
messenger in signal transduction in which DG aids in
activating protein kinase C and IP3 in elevating the
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level of calcium.
Folch in 1949, working with brain lipids, was the
first to. identify a phosphoinositide fraction which on
the basis of chemical analysis appeared to be a
'diphosphoinositide' and Dawson was the first to show
how rapidly they were labeled with 32P in comparison
with the other phospholipids of brain in 1954, though
the chemical structures were still unknown at that time.
When more sophisticated chromatographic methodology
became available, it was shown that PIP and PIP2 were
present in addition to PI (Grado and Ballore, 1961).
Polyphosphoinositides probably occur in all eukaryotic
cells (Downes and Michell, 1982).
4.1 Polyphosphoinositides and receptor activation
There have been several reviews in recent years
dealing mainly with the various aspects of
polyphosphoinositide metabolism and its significance in
receptor activation (Berridge, 1984 Downes and
Michell, 1982 Hawthrone, 1983 Sekin and Hokin,
1986).
The rapid turnover of polyphosphoinositide was
first described in brain by Brockerhoff and Ballou in
1962 and in non-neural tissue by Santiago-Cavo and co-
workers in 1964. In a brain cytoplasmic particulate
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fraction, muscarinic receptor stimulation with
acetycholine caused a 30% loss in PIP. (Santiago-Calvo,
Mule, Redman, Hokin and Hokin 1964). Durell and
associates (Durell, Sodd and Friedel, 1968) observed the
formation of inositol mono-and bisphosphate in
synaptosomes in reaction in response to ACh. and they
suggested that the primary reaction in response to ACh.
was phosphodiesteratic cleavage of PIP and PIP2. In
1977, Abdel-Latif, Akhtar and Hawthorne (1977) showed
that muscarinic cholinergic stimulation of rabbit iris
muscle caused breakdown of PIP2 within 5 minutes, and
this was accompanied by an increase in inositol-1-
phosphate (IP), inositol-4-5-bisphosphate (IP2), and
inositol-1-4-5-triphosphate (IP3). Despite of the
calcium requirement of this response and the ability of
a calcium inophore to mimic the above breakdown, the
possibility that it might play a role in generating
calcium signals was ignored at that time.
The recent revival of interest in
polyphosphoinositides began with the finding that
calcium mobilizing agonists, such as vasopressin in
liver, caused a very rapid breakdown of
polyphosphoinositides particularly PIP2 (Creba, Downes,
Hawkins, Brewster, Michell and Kirk, 1983 Kirk and
Michell, 1981 and Michell, Kirk, Jones, Downes and
Creba, 1981). Unlike the effect in iris smooth muscle
found by Akhtar's group, the breakdown of
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polyphosphoinositides in liver was independent or only
partially dependent on calcium (Creba et al. 1983). The
rapid break down of polyphosphoinositides had also been
confirmed in other. tissues such as parotid gland
Weiss, McKinney and putney, 1982), platelets (Billah and
Lapetura, 1982 Putney, Burgess, Halenda and McKinney
1983), superior cervical sympathetic ganglia (Bone,
Frettern, Palmer, Kirk and Michell, 1984) and
hepatocytes (Creba et al., 1983 Kirk and Michell,
1981). The rapid decrease in PIP2 was independent of
calcium. The breakdown of polyphosphoinositides in
rabbit iris smooth muscle has now been shown to be a
secondary effect due to the release of norepinephrine
(Akhtar and Abdel-Latif, 1984) and cyclooxygenase
products (Rittenhouse, 1984).
It is believed by many that the loss in PI is
entirely due to its phosphorylation to
polyphosphoinositides rather than direct action of
phospholipase C on PI (Agranoff, Murthy and Seguin 1983
Berridge 1983 Michell, Kirk. Jones, Downes and Creba
1AR1)_ This is based on the following observations:
1. faster breakdown of polyphosphoinositides as compared
to PI,
2: earlier appearance of IP3 and IP2 as compared to IP
and
3. an energy requirement to vi a1sdCctL cxli.c
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Thus the whole sequences of the phosphoinositides
and the receptor activation can be summarized as:
1. Interaction of an agonist with its receptor induces
the hydrolysis of polyphosphoinositides by the relevant
phosphodiesterase enzyme to yield two putative
intracellular signals, diacylglycerol and IP3.
2. Resynthesize the lipid precursor so that the whole
cycle can be continued.
4.1.1 Calcium Qatinq hypothesis
The link between receptor activation and inositol
lipid metabolism was first shown by Hokin and Hokin in
1953. In 1975, Michell noted a correlation between the
calcium mobilizing action of certain agonists and the. P1
effect may be antecedent and causally related to calcium
mobilization. The work of Jones and Michell (1974) and
Hokin Neaverson (1974) made it clear that the receptor
linked reaction was of the phospholipase C type. The
substrate at that time being considered to be PI. A loss
of this lipid and production of diacylglycerol could be
measured chemcially. This led to Michell's gating
theory. The support of the calcium gating theory
includes the studies of blowfly salivary gland where
stimulation with 5-hydroxy-tryptamine (5HT) caused PIL
loss and the entry of calcium into the epithelial cells
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(Fain and Berridge, 1979). When a supramaximal
concentration of 5HT was used, this effect was followed
by receptor desensitization and abolition of calcium
uptake. Incubation of washed glands with myoinositol
restored both PI sensitivity to 5HT and calcium
transport (Fain and Berridge, 1979). Because of its
plasma membrane associates and affinity for calcium,
PIP2 is a better-candidate for calcium gating than PI
(Hawthorne and Pickard, 1979).
In spite of the circumstantial evidence suggesting
a role for PI turnover in calcium gating, some of the
following points do not neatly fit into this hypothesis:
1. longer time period for the PI effect to be elicited.
2. calcium dependence of the PI effect in certain
tissues.
3. the endoplasmic reticulum as the site of most of the
PI effect as shown by 3[H] inositol autoradiography and
differential centrifugation (Gerber Davies and Hokin,
1973).
It has only been within the past couple of years
that a role for phosphoinositides in elevating cytosolic
calcium has been established. This has been made
possible by permeabilization of cells with detergents or
by hypotonicity to prevent entry of added inositol-1-4-
5- triphosphate (IP3), an immediate breakdown product of
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PIP2. Addition of less than micromolar amounts of IP3
caused a rapid release into the cytosol of 'trigger
calcium' apparently from the endoplasmic reticulum and
this effect was not mimicked by other inositol
phosphates (Streb Irvine, Berridge and Schulz, 1983
Irvine Brown and Berridge, 1984 Hirata, Suematuse,
Hasimoto, Hamachi and Koga 1984).
4.1.2 DIACYLGLYCEROL
Diacylglycerol is the other immediate-product of
the phosphodiesteratic cleavage of phosphoinositides. A
rapid and transient accumulation of DG associated with
stimulated phosphoinositides breakdown has been
demonstrated in platelets (Haslam and Davidson, 1984
Irvine, 1982 Mauco, Dangelmaier and Smith, 1984
Prescott and Majerus, 1983), mast cells (Igarashi and
Kondo, 1980), pituitary cells (Drummond Bushfield and
Macphee, 1984 Martin, 1983) and liver (Hughes, Rye,
Pickford, Barritt amd Chalmers, 1984 Thomas, Marks,
Coll and Willamsian, 1983). Diacylglycerol which is
mainly of the 1-stearoyl-2-arachi-donoyl-n-glycerol
variety activates a protein kinase distinct from cAMP or
cGMP-activated protein kinase. This kinase termed
protein kinase C, requires phospholipids and calcium for
maximum activity. Its affinity for calcium increases
several fold by diacylglycerol (Kishimoto, Takai, Mori
and Kikawa, 1980). It appears the tumor-promoting
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agents such as phorbol esters can activate at the
diacylglycerol site of protein kinase C in intact cells
(Kikkawa, Kitano, Saito, Kishimoto, Tamiyama, Tamaka and
Nishizuka, 1986).
Thus a -stimulus which cause the breakdown of
polyphosphoinositides would result in the formation of
IP3 and DG. The IP3 branch and the DG branch of the
phosphoinositide cascade appear to act synergisticalll
to phosphorylate proteins. The former by elevatinc
intracellular calcium to activate calmodulin-dependent
protein phosphorylation and the latter to activatE
protein kinase C, which phosphorylates a different set
of proteins. This synergistic interaction pathway hac
been demonstrated in different tissues such as platelet:
(Kaibuchi, Taka.i, Sawamura, Hoshijma, Fuzikusra anc
Hishizuka, 1983. Rink, Sanchez and Hallam, 1983),
lymphocytes (Mastro and Smith, 1983) and mast cell.
(Katakami, Kaibuchi, Sawamura, Takai and Nishizuka,
1984).
4.2 Polyphosphoinositides in myelin
Deshmukh et al., (1981, 1982) had shown that rat
brain myelin has a active pool of polyphosphoinositides.
The greatest incorporation in vivo of 32Pi into these
lipids was in a 'heavy myelin' fraction which may
contain material from the internal or external mesaxon
and membrane loops at the nodes of Ranvier. Both PI and
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PIP were more active in this fraction than in the less
dense myelin fractions. Polyphosphoinositide
phosphomonoesterase was equally active in all fractions.
The phospholipase C attacking these lipids was more
active in the denser fraction of myelin. The results are
consistent with the idea that polyphosphoinositide
metabolism is associated with cation flux at the nodes
of Ranvier. i.e. involvement with axolemma (Deshmukh,
Bear and Brockerhoff 1978 Deshmukh, Kuizon, Bear and
Brockerhoff, 1981 1982).
4.3 Polyphosphoinositides in peripheral nerve
It has been suggested that the lack of inositol
and resulting metabolic disturbances are responsible for
the nerve conduction defects in diabetes (Winegard,
1983). The concentration of free inositol is reduced in
sciatic nerve of streptozotocin-diabetic rats (Greene et
al., 1975 Palmano et al., 1977) and in post-mortem
nerve samples from diabetic patients (Mayhen et al.,
1983). Incubation of sciatic nerve from streptozotocin-
diabetic rats with 32Pi for the study of
polyphosphoinositide labeling lead to controversial
results. Natarajan and his co-workers showed that
incubations of isolated sciatic nerves of diabetics rats
in a medium containing [32P] orthophosphate gave
decreased labeling of phosphatidylinositol and
substantial change in the labeling pattern of
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phosphatidylinositol phosphate and 4,5 bisphosphate from
that of control (Natarajan, Dyck and Schmidt, 1981).
Hawthorne (1983) also observed decreased labeling of
phosphatidylinositol (Ptd Ins) and a decreased labeling
of PIP2 relative to PIP. While Bell and his co-workers
(1982) observed increased labeling of PIP2 but no change
in Ptd Ins 4P in the nerve from diabetic rats. Whether
these changes account for the nerve conduction defect of
diabetes need further studies.
4.4 Polyphosphoinositides and the action potential in
nerve conduction
There is clear evidence of calcium fluxes as well
as the well known sodium and potassium fluxes
associated. with the action potential in nerve
conduction.
Is the polyphosphoinositides metabolism involved
in the permeability changes accompanying nerve impulses?
Little is -known about this possible mechanism. Several
papers may be of interest to discuss here:
1. Simmons and his co-workers in 1982 provide evidence
that Ptd Ins turnover may regulate sodium/ potassium
ATPase activity in endoneurium from rabbit vagus nerve.
This sodium pump ATPase is a plasma membrane enzyme and
its activation by acidic phospholipids has been a
controversial subject.
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2. Hayashi and his co-workers in 1966 showed that sodium
ions stimulated labeling of polyphosphoinositides with
32p in brain slices.
3. Akhtar and Abdel-Latif in 1982 showed that in rabbit
iris smooth muscle, acetylcholine stimulated labeling of
Ptd Ins and phosphatidate with 32 P, and breakdown
of polyphosphoinositides in labeled muscle, only in the
presence of both sodium and calcium ions. In the absence,
of sodium ion from the medium, the specific
radioactivity of iris muscle. ATP fell to about 1/5 with
a corresponding decrease in phospholipid labeling.
Abdel-Latif (1983) suggested that muscarinic-induced
entry of calcium leads to breakdown of phosphoinositides
in the iris muscle cell and this in turn facilitates
entry of sodium. Recycling of the phosphoinositides is
associated with outflow of sodium (sodium/ potassium
ATPase). Although this mechanism is fairly speculative,
the possible link between sodium pumping and the
polyphosphoinositides deserves further study.
4.• Hendrickson and Reinertsen (1971) showed that the
conversion of triphosphate to diphosphate would result
in a release of 70% bound Ca2+ and a 25% decrease in
ligand change. Changes of this magnitude occurring on
one side of the nerve axon. membrane could conceivably
bring about a re-organization of the membrane with a
resulting changes in Na+ and K+ permeability.
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5. There are high metabolic activities of the inositides
in nerve cell bodies, myelinated as well as poorly
myelinated nerve fibres. Stimulation of vagus nerve for
30 minutes increased phosphate incorporation into the
phospholipids but the increase has been significant only
in the case of IP3 and IP2. Tetrodotoxin at
concentration sufficient to block transmission had no
effect upon phospholipid labeling in vagus or phrenic
nerve. Ouabain at blocking concentration did not affect
polyphosphoinositide in vagus nerve but increased [32P]
labeling of the other phospholipids (White, Schellhase
and Hawthorne, 1974).
4.5 Neomycin and the peripheral nerve conduction
The. aminoglycosides have been use as tool to
study the metabolism of phosphoinositides in signal
transduction. It has been used to study the signaling
system in. a number of tissues (Schibeci and Schacht,
1977 Schacht et al. 1978 Carney, Scott, Gordon and
Labelle, 1985 Cockcroft and Gomperts, 1985 Prentki,
Deeney, Matschinsky and Joseph, 1986 Schacht, 1986).
The hypothesis put forward in the present study is
neomycin may directly affect the nervous conduction by
changing the permeability of the Na+ and/ or the K ions
or indirectly by affecting the phosphoinositide
metabolism in the nervous tissue.




1. Interpretation of the Compound Action Potential
Extracellular stimulation and recording.
In 1924, Erlanger and Gasser reported their
classical study of motor and sensory conduction in
bullfrogs and dogs. They demonstrated the proportional
relationship between conduction velocity and diameter of
peripheral nerves. Since then, advances had been made to
improve the instruments used to measure nerve
conduction. Experimental technique had been improved
from extracellular recording of whole nerve trunk to
single unit extracellular recording by Tasaki and his
co-workers (1982).
The nervous activity in the nerve fibre is
accompanied by electrical changes which appears across
the cell membrane. Such electrical changes can cause
electric currents to flow in the cytoplasm of the cell
and also in the surrounding conducting fluids. Nervous
activity can thus be investigated by either recording
the potentials appearing across the membranes or in the
extracellular fluids. Conversely by the use of an
external source of electromotive force, an electric
field can be established through the extracellular
fluid, and some of the current which flows can traverse
cell membranes affecting the membrane potential and when
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the stimulus is high enough i.e. above the threshold of
the action potential, action potential can be elicited.
In extracellular recording, two electrodes are placed
in the extracellular fluid surrounding the nerve fibres.
The recorded potential is the potential difference in
the extracellular fluid between the two regions where
the electrode make their contact. When two closely
spaced electrodes lying side by side along a line
parallel to the longitudinal axis of the axon, an
biphasic action potential is obtained.
Extracellular recording has its advantages of being
easy to operate and without causing any traumatization
to the intracelluar structure.- They are particular
useful in long terms experiments and simultaneous
multilead recordings from different structures.
The magnitude of the extracellularly recorded
signal depends on a number of factors which include the
distance between the neural membrane (axolemma) and the
recording electrodes and the electrical properties of
the interposing non-neural tissue and the surrounding
medium. 'In compound action potential, it is a algebraic
sum of the contribution from each fibres. A resultant
signal in terms of millivolts in amplitude can usually
be obtained.
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2. The use of frog sciatic nerve for the investigation
of Action Potential.
The sciatic nerve of the frog had once been
the most frequent material used by physiologists for
investigating excitability phenomena. Sciatic nerve is
selected here for the pilot study mainly because it is
relatively easy to dissect and the results can be
compared with those from other workers.
3.The choice of rat-tail for in vivo study of
conduction of nervous impulses.
The results obtained from the in vitro study
of the compound action potential of the frog sciatic
nerve cannot be compared with the living mammalian
species. Moreover, the original design of the
experimental set-up does not allow an accurate detection
of the C-potential. It is. because the stimulation sites
and recording sites are too close together making it
difficult to disperse the A potential from the C
potential. Therefore, the next step of the experiment
involves in vivo study of mammalian nerve fibres. The
coccygeal nerve roots which supply the rat tail is
selected in this experiment on the account that it is
easier to measure the exact conduction distance as the
course of the nerve is relatively straight and a
ccnuction distance of 10 cm. can easily be obtained.
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4.Morpholoy of the rat-tail muscles
The rat-tail is innervated from six pairs of
dorsal and ventral coccygeal roots. One spinal segment
usually innervates four muscular segments. Outside the
vertebral column the roots join to form one dorsomedial
and one ventrolateral longitudinal nerve trunk on each
side. The two dorsal nerve trunks supply the dorsal
muscles and the skin at the dorsal aspect aspect of the
tail. The lateral and ventral muscles and skin region
get their innervation from branches of the ventrolateral
longitudinal nerve trunks. The innervation to the dorsal
and ventral muscles are mixed nerve and contain skin
nerve fibres branching off from the muscle nerves (Stag,
1964).
5. Ionic permeabilities of the perineurium
The perineurium forms a continuous multilayer
sheath around the fascicles of peripheral nerves. The
fascicles are in turn surrounded by a connective sheath
- the endoneurium. The perineurium composes of a
variable number of concentric layers of thin flat cells
on both sides with collagen fibrils interspersed between
the layers of cells (Low, 1976). The adjacent cells of a
layer and sometimes cells of adjacent layers are held
together by intercellular tight junctions (zonulal
occludentes) and a sparse number of desmosomes. These
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morphological feature contribute to the diffusion
barrier properties of the perineurium to small ions
(Krnjeviv, 1954). The endoneurial space which surrounds
the axons of peripheral nerves is delineated by the
perineurium and endoneurial vasculature, these two
structure constitute blood nerve barrier. Just as the
blood-brain barrier regulates the immediate fluid
environment of the elements of the central nervous
system, the blood-nerve barriers controls the micro-
environment of the peripheral axons.
Recent studies by Weerasuriya and his coworkers
had shown that there was no evidence to suggest active
transperineurial transport of sodium ion or potassium
ion the paracellular routes of transperineurial
permeation of sodium, potassium chloride ions and
[14 C] sucrose exhibited a size-dependent
permselectivity to these solutes.(Weerasuriya, Rapoport
and Taylor, 1980 Weerasuriya and Rapport, 1986
Weerasuriya,1987). In view of the above findings. A
desheathed nerve is necessary in order to facilitate the




1. In vitro study of conduction of A compound Action
potential in frog sciatic nerve
1.1. Preparation of frog sciatic nerve
Leopard frog (Rana pipiens) of either sex
were used in this study. The frog was paralyzed by
physical destruction of the central nervous system by
the double-pithing method. The skin was cut around the
body at the abdominal region and was then pulled
downwards and off the lower part of the body and legs.
It was then laid on its ventral surface on a paraffin
board. The sciatic nerve was identified which lies
between the- semitendinosus and semimembranosus muscle.
It was then separated carefully from the surrounding
connective tissue with forceps to pull on adjacent
tissues and the hooked glass rod to lift gently the
nerve. A pair of fine scissors was used to free the
connective tissue from the nerve especially where the
nerve passes through the knee joint. At all stages, the
nerve was kept moist by'wetting with Ringer solution at
room temperature of 200C. The sciatic nerve between the
upper part of thigh and lower one-third of the calf
region was then dissected out. It was then transferred
to a Ringer solution bath bubbled with 95% oxygen and
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5% carbon dioxide at room temperature of 20°C.
1.2 Preparation of the desheathed nerve fibre.
The nerve was desheathed by a
longitudinal incision through the epineurium layer with
a sharp dissecting knife. The sharp knife blade was
prepared by breaking the edge of a double sided carbon
razor blade (Eagle brand, China) with a pair of pointed
pliers. The blade was examined under the microscope to
ensure that the point edge was sharp enough. An
'Eclipse' pin vice was used to fix the blade and acted
as a holder. The two ends of the nerve were tied with
thread so as to facilitate placement of the nerve onto
the nerve chamber at the next stage.
A plastic chamber, as shown on diagram 2, was
pierced by silver/silver chloride electrodes spaced at
prearranged distances was made. The chamber was
separated into 3 parts by 2 partitions which was
connected by 2 round holes which allowed subsequent
passage of the nerve. An inlet which was made from a
hypodermic needle was arranged in the middle chamber so
as to allow constant bubbling of 95% oxygen and 5%
carbon dioxide. The nerve was passed alternating above
and below each electrode from one to other. Good contact
of the nerve with the electrode was ensured by allowing
a little tension applied onto the thread which tied the











Diagram 2 In vitro study of conduction of
A coumpound action potential in Frog sciatic nerve
EXPERIMENTAL SET-UP-
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two end of the nerve. Agar solution was used to fill the
holes so that the three chambers are separated from each
other. The middle chamber was either filled with Ringer
solution, neomycin in Ringer solution or 20 mM KCL in
isotonic Ringer solution. The other two chambers were
filled with liquid paraffin to prevent drying of the
nerve, isolate it from the air and acted as an
electrical insulating medium to reduce any possible
shunting of current.
1.3 Stimulation and recording of the A-compound Action
Potential
At one end of the nerve, stimulating
electrodes were connected to an isolated stimulator
(Digitimer, model DS 2). A pair of recording electrodes
was connected to a differential amplifier (Neurlog, NL
103). A ground electrode was placed between the two
pairs of electrodes.
The desheathed sciatic nerve was stimulated at
one end with electrical stimulus from the stimulator.
The duration of the stimulus was maintained at 0.06 ms
Threshold of the A compound action potential was
determined by gradually increasing the stimulus
strength. The threshold voltage required to elicit an
action potential was recorded. Supramaximal stimulation
for the A fibres was then given. A train of eight
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stimuli with intervals of-1 second was then given. Ar
interval of one minute was allowed between each set of
stimuli. After a stable compound action potential was
established, the Ringer solution was then replaced
either by Ringer solution with neomycin (3500 mg/1) or
20 mM KCL in isotonic Ringer solution. The resultant
osmolarities were in the range of 221-225, 224-231 and
221-225 mOsm/kg. respectively. Change of solution was
made with a tube system attached to a roller pump. The
electrical stimulation was continued for the next 30
minutes and recorded signals were amplified by the
Neurolog amplifier system.
The compound action potential in response to
the electrical stimulation were amplified with a
differential amplifier (Neurolog 103) (100x), filtered
(Neurolog NL 125) averaged (Neurolog Nl 750) and
displayed on a storage oscilloscope (Tektronix 5130N).
The differential amplifier was used to minimize the
interference and the balance, the potentiometer on the
amplifier, was adjusted to minimize common mode signals
such as mains interference or shock artifacts present in
the recording and to avoid any DC background which would
affect the averaged compound action potential. Ground
level were adjusted prior to the recording of the action
potential. The differential amplifier was used to
minimize the interference. The bandwidth of the filter
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was set from 60 Hz. to 1.5 kHz. The averaged compound
action potential was recorded on a single channel chart
recorder (Graphtec miniwriter model WTR 771A) and was
later used for calculation of the conduction velocities
and the amplitude of the action potential. The
conducting distance was measured with a caliper between
the stimulating and recording electrodes.
1.4 Preparation of the Ringer solution.










The solution was bubbled with 95% .02 and 5%
CO2. pH value was maintained at 7.45+ 0.05.
1.5 Preparation of the Neomycin (3500 mgfi) in Ringer
solution.
Neomycin sulphate (Mycifradin, Upjohn) was used in
this study. Stock solution was made by dissolving 350 mg
of neomycin with 10 ml of Ringer solution. Each ml of
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the stock solution was mixed with 9 c.c of Ringer
solution. The concentration of the final neomycin
solution would thus be 3500 mg/l or 127.9 mM.
• pH of the solution was maintained at 7.45+ 0.05
and bubbled with 95% 02, 5% CO2.
1.6 Preparation of 20 mM KCL in isotonic Ringer
solution.










pH was maintained at 7.45 +0.05 and bubbled with 95
02, 5% CO2.
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1.7 Data and statistical analysis
The latency as well as the peak amplitude were
determined on the chart recorder. For the determination
of the conduction velocity of the A potential, it is
assumed that the acute effect of neomycin would only
take place in the portion of the nerve which was
actually immersed with neomycin solution. Any change in
latency was presumed due to the effect on the immersed
nnrtinn_
The relative change in the amplitude and the
conduction velocity were also determined. This was done
in each individual experiment. The amplitude and the
conduction velocity recorded before the application of
neomycin or KCL were taken as 100%. Any change in
amplitude or conduction velocity was relative to a
change in this value.
Statistical analysis of the conduction velocity and
the average amplitude was carried out using the oneway
analysis of variance. The null hypothesis was that there
was no significant difference between the control and
the treated period. The significant level was set at P
0.05. Statistical analysis was performed by the
statistical package SPSS/PC (Statistical Package for the
Social Science). The results of the data were expressed
as mean+ standard deviation of mean.
To test the reliability of the experimental set
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up, oneway analysis of the control group was performed.
The null hypothesis was there was no significant
difference in the amplitude and the conduction. velocity
between each period of time.
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2. In vivo study of conduction of action potential in
rat ventrolateral tail nerve
2.1 General preparation
Sprague-Dawley rats of either sex of body
weight about 350g were used in this study. The animals
were anesthetized with urethane (20% w/v. 6 ml/kg
i.p.), (Sigma, U.S.A.). Supplementary doses of about
0.5 ml were given i.p. if necessary. One carotid artery
was cannulated for monitoring of arterial blood
pressure. The mean blood pressure was normally at 100
mm Hg. The body temperature was kept at 380C by a
thermostatically controlled electric blanket
(Bioscience, CFP-8185).
The rat was laid on its dorsal surface. The
rat tail was enclosed by a U-shaped glass tube with warm
water continuously circulated around it by a Watson
Marlow peristaltic pump (model 502 S). The water was
kept warm at 380C by a water bath which was
thermostatically set at 380C Two subcutaneous
thermistor probes were placed on the proximal and
distal end of the rat-tail to monitor the subcutaneous
temperature throughout the experiment.
The ventrolateral tail nerve which supplied
the lateral and ventral muscles was used in this
experiment. Three incision sites of about 2.5 cm each
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were made in the scrotal, middle and distal region of
the tail. The incisions, were made slightly lateral so as
to avoid any possible damage to the blood vessel which
lies in the central region of rat-tail. Threads were
then fixed to the skin around the incision sites for the
attachment of the skin flap to a ring system of screws
to form pool which to be filled with liquid paraffin
(Riedel de Haen, DABB) or Krebs solution.
2.2 Surgical procedures
The ventrolateral tail nerve lies
underneath the tendon units. Some of the tendon units
had to be removed for adequate exposure of the nerve.
Care had to be taken here to avoid any damaged to the
nearby blood vessels. The dissection was carried out
under a dissecting microscope (Wild, Model M 650)-,
(Magnification 6-40x). The connective tissue around the
nerve was freed from the nerve trunk with two fine
forceps and was subsequently dissected with a pair of
fine iris scissors. A hooked glass rod was used to
gently lift the nerve so' as to free the nerve from the
surrounding tissue. At all stages, the pool was bathed
with Krebs solution. The freeing of the nerve was then
repeated in the other 2 sites. Desheathing of the nerve
was performed in the central pool which was subsequently
exposed to Krebs solution or other test solution. The
nerve was desheathed by a longitudinal incision through
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the epineurium layer with a sharp dissecting knife. The
preparation of the sharp knife has been described in the
previous section. The dissection was carried out under
the dissecting-microscope with magnification of. 40x. Any
tissue fluid and blood which accumulated after the
dissection was removed by using Pasteur pipettes and
small pieces of lint cloth. The proximal and distal pool
was then filled with warm liquid paraffin at about 34 °C
to prevent drying of the nerve, to isolate it from the
air and to act as an insulating medium to reduces any
possible shunting of the circuit. The middle pool was
filled with either Krebs solution, 10 mM K2SO4 in
Krebs solution or Krebs solution with neomycin (3500
mg/1). The solution was infused into the pool through a
syringe pump (Harvard apparatus) at a rate of 0.5 ml per
min. The solution was kept warm by running through a
chamber with circulating water of 38°C. The solution in
the pool was constantly carried away by a roller pump
system (Perista pump SJ- 1211).
The electrode placement, screw ring system and the












Diagram 3 In vivo study of conduction of A and C
potential in rat ventrolateral tail nerve
- electrode placement.
screw ring system to form the pool
U-shape glass tube





Diagram 4 In vivo study of conduction of A and C potential in rat
ventrolateral tail nerve- Experimental set-up showing
screw ring system and U shape glass tube.
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2.3 Stimulation and recording of A and C compound
Action Potential
Bipolar silver-silver chloride hook
electrodes were used as stimulating and recording
electrodes. Two micro-manipulators (Prior, England) were
used to allow three dimensional fine adjustment of the
electrode onto the nerve fibre. The stimulating
electrode was placed at the caudal end so that muscle
contraction was minimized. The stimulating voltage was
supplied by an insulated stimulator (Digitimer, Model
DS2) and was triggered by the Digitimer (D4030). The
recording electrode was connected to a differential
amplifier (Neurolog NL103). A pointed silver wire which
acted as the ground electrode was inserted into the
surrounding muscle to work as an earthing electrode.
Electrical stimulation was given distally,
the duration of each stimulus was maintained at 0.1 and
1 ms respectively for A and* C potential. A square wave
form of impulse was given. Threshold of the A compound
action potential was first observed. C compound action
potential was subsequently detected by gradually
increasing the stimulus-strength. The stimulus strength
required to elicit the A or C potential was recorded.
Supramaximal stimulation for the A or C fibres were then
given. A train of stimulation which consisted of ten
stimuli were given. A rest period of 10 s was given
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between each stimulus. An interval of 5 minutes was
allowed between the trains of stimuli. Either the A or C
potential was recorded throughout one set of experiment.
The A or C compound action potential in
response to the electrical stimulation were amplified
with differential amplifier (Neurolog NL 103), filtered,
(Neurolog NL 125), and further amplified (NL 106 AC-DC
amplifier). The balance and ground level was adjusted
and the recording electrodes were positioned carefully
so as to get the least possible ground noise or
background DC level. The differential amplifier was used
to amplify the incoming signal and minimize the
interference. The amplification was 1000x. The filter
was set to a bandwidth of 60 Hz. to 1.5 kHz.
The original recordings of the nervous impulses
from the differential amplifier were stored with a four
channel FM tape recorder (Hewlett Packard 3946A). One
channel was used for the recording of the nervous
impulses while one direct channel was used to record the
synchronized trigger pulses from the digitimer D4030
which control the stimulator. The direct channel also
recorded the voice which described the particulars of
each set-of stimuli. Tape speed was set at (3 3/4 per
s.). The nervous potential from the differential
amplifier were also converted into digital signal by the
CED 1401 AD convertor to a 8087 based microcomputer and
stored on floppy diskettes for later data analysis. The
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instantaneous potential as well as the averaged
potential were displaced on a storage oscilloscope
(Tektronix 5130N). Averaged-potential was recorded on a
two channel chart recorder( Miniwriter WTR 751). The
conducting distance was measured with a caliper between
the stimulating and recording electrodes.
After a stable A or C potential was established,
Krebs solution with neomycin (3500 mg/l) was infused
into the pool at an infusion rate of 0.5 ml per min.
Trains of stimuli as described were continued for the
next 60 minutes and recordings were made with the
Neurolog amplifier system. After one hour of exposure to
neomycin solution, the nerve was washed with Krebs
solution with a infusion rate of 0.5 ml per min. Trains
of stimuli as described were given in the next 30
minutes. Compound action potentials were recorded to see
if there was any change with the Krebs solution. After
30 minutes, the solution was changed to 10*MM K2SO4
which gave 20 mM of K+ ions in the Krebs solution. When
complete blocking of the potential was established, the
nerve was then flushed with Krebs solution to see the
reversibility of the effect of hyperkalemia.
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2.4 Preparation of the Krebs solution






KH2 PO4 1.2 mM
11.1 mmD-glucose
162.5 mMTotal
The osmolarity was in the range of 294-300 mOsm/kg
and the solution was bubbled with 95% 02 and 5% C02-
pH was maintained at 7.35+ 0.05.
2.5 Preparation of Neomycin solution in Krebs solution.
Neomycin sulphate (Mycifradin, Upjohn) was used
in this study. Stock solution was made by dissolving 350
mg of neomycin with 10 ml of Krebs solution. Each ml of
the stock solution was mixed up with 9 ml. of
Krebs solution. The concentration of the final neomycin
solution would thus be 3500 mg/l or 168.2 mM. and the
osmolarity was 297-303 mOsm/Kg.
pH was maintained at 7.35 +0.05 and the solution
was bubbled with 95% 02, 5% CO2.
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2.6 Preparation of 10 mM K2SO4 in Krebs solution.










pH was maintained at 7.35+0.05 and the solution was
bubbled with 95% 02, 5% CO2.
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3 DATA STORAGE
The nervous potential from the differential
amplifier were converted into digital signals with the
CED 1401 AD convertor. The data storage computer program
required 4k bytes of memory for each of data or
stimulation. A typical waveform of 250 msec will require
a 2500 sample points i.e 10 sample points were allocated
to each msec which gave a fine resolution of change in
amplitude in every cosec. Data storage included the
automatic determination of the baseline which was done
by sampling the ground noise level before the
stimulation. Data were also stored on magnetic tape for
later retrieval.
3.1 MAGNETIC TAPE
A Hewlett Packard 3964A four channel tape
recorder was used. One FM channel was used for the
recording of the nervous impulse. The channel was
calibrated to give an output signal of the same
amplitude as the input signal. The original nervous
impulses from the recording electrode were stored on
tape after amplification by 1000x by the differential
amplifier. The direct channel was used to record the
synchronized trigger pulses from the digitimer D4030
which controlled the stimulator. It also recorded the




The data analysis program allows-retrieval of-the
original potential on screen and can determine the
latency, peak potential, full wave rectification and
integration of the potential. The latent period of the A
and C potential can be traced on screen by the cursor.
The accuracy of the cursor movement was +0.1 ms.
Therefore, the accuracy of the latent period was within
0.1 ms. For the A potential, the earliest peak i.e. the
fastest conduction velocity was located by the cursor.
Latency was shown on screen as well as on the printer.
In the C potential, the shortest and longest latent
period were located on screen by the cursor and was
subsequently shown on screen and the printer. Besides
the latent period, the range of either A or C potential
was located by the cursor and full wave rectification of
the whole range was performed. Integration of these
range divided by the interval would thus give the
average amplitude of the A and C potential respectively.
Since integration of the range would inevitably involved
the ground noise, determination of the baseline or zero'
line was necessary before the actual integration. This
was performed by the data analysis program which was
done by sampling the ground noise level before the
stimulation. In the data storage program, 10 sample
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points were allocated to each ms. Therefore, a fine
resolution of change in potential in every ms. can be
achieved.
For the determination of the conduction velocity
of A and C potential, It is assumed that the acute
effect of neomycin would only be taken place in the
portion of the nerve actually immersed with neomycin
solution. Any change in latency was the result of the
effect at the immersed portion.
The relative change in the amplitude and the
conduction velocity were also determined. This was done
in each individual experiment. The amplitude and the
conduction velocity recorded before the application of
neomycin or K2SO4 were taken as 100%. Any change in
amplitude or conduction velocity was a relative change
to this value.
3.3 STATISTICAL ANALYSIS
Statistical analysis of the conduction velocity and
the average amplitude was carried out using the oneway
analysis of variance. The null hypothesis was that there
was no significant difference between the control and
the treated period. The significant level was set at P
0.05. Statistical analysis was performed by the
statistical package SPSS/PC (Statistical Package for the
Social Sciences). The results of the data were expressed





l..l FROG SCIATIC NERVE:- CONTROL STUDIES
In the control studies, six frogs of both sexes
were used. The mean value threshold value to elicit a
compound action potential was 0.47+ 0.11 V. The
stimulating voltage was the supramaximal stimulus above
which further increase in stimulus will not lead to any
increase in amplitude and changes of the conduction
velocity. Mean value-of the stimulating voltage in this
series of experiments was 4 +0.9 V. The stimulation
duration was fixed at 0.06 ms. The temperature of the
nerve chamber throughout the experiment was 20.5 +0.5
°C. pH of the Ringer solution was within the range of
7.43+ 0.01. Details of the data with the minimum,
maximum, mean and standard deviation are listed in
Table 1.
NEOMYCIN STUDIES
Fourteen frogs of both sexes were used. Mean
value of the threshold was 0.5+ 0.13 V. The mean
stimulating voltage was 4.8+ 1.6 V. Stimulation
duration was again fixed at 0.06 ms. The mean
temperature inside the nerve chamber was 20.6 +0.8 °C.
pH was within the range of 7.42+ 0.01. Details of the
data with the minimum, maximum, mean and standard
deviation are listed in Table 2.
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20 mM KCL IN ISOTONIC RINGER SOLUTION
6 frogs of both sexes were used. Mean value of
the threshold. was 0.47+ 0.1 V. Mean value of the
stimulating voltage was 4.6+ 2.4 V. Stimulation
duration was again fixed at 0.06 ms. Mean temperature
inside the nerve chamber was 20.7 +0.5 0C. pH value was
within the range of 7.42 +0.1. Details of the data with
the minimum, maximum and standard deviation are listed
in Table 3.
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A COMPOUND ACTION POTENTIAL
FROG SCIATIC NERVE
DATA OF THRESHOLD, STIMULATING VOLTAGE AND DURATION
TEMPERATURE AND pH VALUE
THRESHOLDMODE DURATION STIMULATING TEMP. pH value
in V. in msec VOLTAGE in Celsius
in V.
TABLE 1:- CONTROL
0.3 .06Minimum 3.0 20.0 7.42
0.6 .06Maximum 5.0 21.0 7.43
0.475 .06Mean 4.0 20.5 7.43
StdDev 0.117 0.00 .9 .5 .01
6N 6 6 6 6














1.2RAT VENTROLATERAL TAIL NERVE
A COMPOUND ACTION POTENTIAL
Six rats of both sexes with weights of about 350 g
were used. Mean value of the threshold was 0.3 +0.2 V.
Mean stimulating voltage was 3.4 +1.6 V. Stimulus
duration was kept at 0.1 msec. The mean conductive
distance which is the distance between the stimulation
electrode and the recording electrode was 9.1 +0.8 cm.
The temperature recorded at the caudal part of the rat-
tail was 33°C. pH of the Krebs solution, neomycin and
10 MM K2SO4 Krebs solution were within the range of
7.36 +0.02, 7.32 +0.03 and 7.37 +0.02 respectively.
The details of the data with the minimum, maximum, mean
and standard deviation are listed in Table 4.
1.3 C-POTENTIAL
Nine rats of both sexes with weights of about 350
g were used. The minimum voltage required to elicit the
C potential was taken as its threshold. The mean
threshold voltage was 1.4 +0.6 V. Any potential with
conduction velocity below 2.5 m/s was classified as C
potential (Gasser, 1950). The stimulating voltage was
defined as the supramaximal stimulus in which further
increase in stimulus would not lead to any increase in
the amplitude and the conduction velocity of the C
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potential. The stimulating voltage required in this
series of study was 14 +3 V. Stimulating duration was
kept at 1 ms. The average conductive distance was 10.0
+0.8 cm. Mean temperature was 33 +1 0C. pH of Krebs
solution, neomycin and 10 mM K2SO4 Krebs solution were
within the range of 7.34 +0.051 7.33 +0.02 and 7.34+
0.02 respectively. Details of the data with minimum,




A COMPOUND ACTION POTENTIAL
RAT VENTROLATERAL TAIL NERVE
DATA OF THRESHOLD, STIMULATING VOLTAGE AND DURATION
TEMPERATURE AND pH VALUE
p HTEMP. PHTHRESHOLD STIMULATING CONDUCTIVE pH

















C COMPOUND ACTION POTENTIAL
RAT VENTROLATERAL TAIL NERVE
DATA OF THRESHOLD, STIMULATING VOLTAGE AND DURATION
TEMPERATURE AND pH VALUE
pH PHTEMP.THRESHOLD STIMULATING CONDUCTIVE pH














AMPLITUDES AND CONDUCTION VELOCITIES
OF
A AND C COMPOUND ACTION POTENTIAL
2.1 FROG SCIATIC NERVE
AMPLITUDES OF A COMPOUND ACTION POTENTIAL:-CONTROL
STUDIES
Table 6 lists the minimum, maximum, mean and
standard deviation of the potential of 6 frogs sciatic
nerves. When the potential was stabilized, stimulation
was given every minute for 30 minutes. The change in
amplitude was plotted against time. Figure 1 represents
the changes in amplitudes with time. Results were
expressed as mean +SEM. The mean value at the beginning
of the treatment was 2.92 +0.45 mV. and the mean value
at the end of treatment was 3.04+ 0.47 mV. There was
no significant difference between the changes in
amplitude with the time (p 0.05).
When the value obtained from the first stimulus
was taken as 100%, the change in amplitudes of the
potential is shown in figure 2.
CONDUCTION VELOCITIES
Table 7 lists the minimum, maximum, mean and
standard deviation of the conduction velocities of 6
frogs sciatic nerves. The change in conduction
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velocities was plotted against time. Figure 3
represents the change of the conduction velocities
with the time. Results were expressed as mean +SEM. The
mean value-at the beginning of the treatment was 21.8+
1.2 m/s. and the mean value at the end of treatment was
21.9+ 1.1 m/s. There was no significant difference
between the change in conduction velocity with time (p
0.05). When the value obtained from the first
stimulus was taken as 100%, the change in conduction
velocities is shown in figure 4.
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TABLE 6











































TIME AMPLITUDE CHANGE OF
in minutes in mV AMPLITUDE IN(%)
OF CONTROL
17 (2)
Minimum 1.70 L00. 00
Maximum 4.40 L00. 00
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A COMPOUND ACTION POTENTIAL
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Figure 1 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with Ringer solution for 45 minutes.
Stimulation was given every minute from 15
minutes onward. Peak amplitude was plotted
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Figure 2 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with Ringer solution for 45 minutes.
Stimulation was given every minute from 15
minutes onward. Change in amplitude was








A COMPOUND ACTION POTENTIAL
FROG SCIATIC NERVE




































A COMPOUND ACTION POTENTIAL
FROG SCIATIC NERVE
DATA OF CONDUCTION VELOCITY
CONTROL STUDIES
TIME CONDUCTION CHANGE OF
VELOCITYin minutes CONDUCTION VELOCITY
































A COMPOUND ACTION POTENTIAL
FROG SCIATIC NERVE
DATA OF CONDUCTION VELOCITY
CONTROL STUDIES
TIME CONDUCTION CHANGE OF
in minutes VELOCITY CONDUCTION VELOCITY
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27 (12)
Minimum 18.8 100.00
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Figure 3 are the data of A compound actior
potentials of-6 frog sciatic nerves treated
with Ringer solution for 45 minutes.
Stimulation was given every minute from 15
minutes onward. Conduction velocity was














0 5 10 15 20 25 30 35 40 45
TIME (minutes)
Figure 4 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with Ringer solution for 45 minutes.
Stimulation was given every minute from 15
minutes onward. Change in conduction velocity
was plotted against the time. Results were








AMPLITUDES OF COMPOUND ACTION POTENTIAL
Table 8 lists the minimum, maximum, mean and
standard deviation of the potential of 14 frog sciatic
nerves. The change in amplitude was plotted against
time. Figure 5 represents the change in amplitude with
time. Results were expressed as mean+ SEM. The mean
value at the beginning of treatment was 2.55 +0.29 mV.
and the mean value at the end of treatment was 2.57+
0.29 mV. There was no significant difference between
the change in amplitude with time (p 0.05). When the
value obtained before the application of neomycin was
taken as 100%, the change in amplitude with time is
shown in figure 6.
CONDUCTION VELOCITIES
Table 9 lists the minimum, maximum, mean and
standard deviation of the conduction velocities of 14
frog sciatic nerves. The change in conduction velocity
was plotted against time. Figure 7 represents the
change in conduction velocity with time. Results were
expressed as mean +SEM. The mean value at the beginning
of the treatment was 21.6 +0.5 m/s and the mean value
at the end of the treatment was 21.5 +0.4 m/s. There
was no significant difference between the change in
amplitude with time (p 0.05). When the value obtained
from the first stimulus was taken as 100%, the change
in conduction velocity is shown in figure 8.
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TIME (minutes)
Figure 5 are the data of A compound action
potentials of 14 frog sciatic nerves treated
with 5.7 mM neomycin in Ringer solution for 30
minutes. Neomycin was given from 15 minutes
onward. Peak amplitude was plotted against
time. Results are expressed as mean +SEM. No
significant change was found before and after
the exposure of neomycin solution (P 0.05)
AMPLITUDE
(mV)
A COMPOUND ACTION POTENTIAL
( FROG SCIATIC NERVE)
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TIME (minutes)
Figure 6 are the data of A compound action
potentials of 14 frog sciatic nerve treated
with 5.7 mM neomycin for 30 minutes in Ringer
solution. Neomycin was given from 15 minute
onward. Change in amplitude was plotted
against the time. Results were expressed as
mean +SEM. No significant change was found
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Figure 7 are the data of A compound action
potentials of 14 frog sciatic nerves treated
with.5.7 mM neomycin in Ringer solution for 30
minutes. Neomycin was given from 15 minutes
onward. Conduction velocity was plotted
against the time. Results were expresssed as
mean +SEM. No significant difference was found
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TIME (minutes)
Figure 8 are the data of A compound
action potentials of 14 frog sciatic nerves
treated with 5.7 mM neomycin in Ringer
solution for 30 minutes. Neomycin was given
from 15 minutes onward. change in Conduction
velocity was plotted against the time.
Results were expressed as mean + SEM. No
significant difference was found before and








The digitized recording of the effect of acute
exposure of neomycin on the nervous conduction is shown
in figure 9.
FROG SCIATIC NEHVE







Figure 9 In vitro study of action potential
in frog sciatic nerve, original recording of
the action potential before and during
,exposure to 5.7 mM neomycin solution in Ringer


































20 mM KCL IN ISOTONIC RINGER SOLUTION
Table 10 lists the minimum, maximum, mean and
standard deviation of the potential of 6 frogs sciatic
nerves. The change in amplitude was plotted against
time. Figure 10 represents the change in amplitude
with time. Results were expressed as mean+ SEM. The
mean value at the beginning of the treatment was 1.77
0.16 mV and the mean value at the end of treatment was
0.50 0.19 mV which was 26.87± 9.98% of the pre-
treatment value. When the nerve was flushed with Ringer
solution, gradual return of the amplitude was shown. By
15 minutes, the mean value was 1.55 +0.09 my which was
96.94 +1.8% of the pre-treatment value). Significant
different between change in amplitude with time was
found at 14 and 15 minutes after the application of KCL
solution.(p<0.05). When the value obtained from the*
first stimulus was taken as 100%, the change in
amplitude with time is shown in figure 11.
CONDUCTION VELOCITIES
Table 11 lists the minimum, maximum, mean and
standard deviation of the conduction velocities of 6
frogs sciatic nerves. The change in conduction velocity
was. plotted against time. Figure 12 represents the
change in conduction velocity with time. Results were
expressed as mean +SEM. The mean value at the beginning
of the treatment was 23.6 +0.9 m/s and the mean value
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at the end of treatment was 14.7 +0.8 m/s. When the
nerve was flushed with Ringer solution, there was
gradual increase of the conduction velocity. At 15
minutes, the mean value was 22.0 +1.9 m/s. When the
value obtained before the application of KCL solution
was taken as 100%, the change in conduction velocity
with time is shown in figure 13.
Figure 14 shows the sequence of blockade of the
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PO mU KCL started
-Wash with Ringer solution
0
0 5 10 2015 25 30 35 40 45
TIME (minutes)
Figure 10 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with 20 mM KCL in isotonic Ringer solution for
15 minutes and was subsequently washed with
Ringer solution for another 15 minutes. Peak
amplitude was- plotted against the time
Results were expressed as mean+ SEM.
Significant difference from control values was
found at 14 and 15 minutes after application
of 20 mM KCL in isotonic Ringer solution (P
0.05).
AMPITUDE(mV)
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Figure 11 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with 20 mM KCL in isotonic Ringer solution for
15 minutes and was subsequently washed with
Ringer solution. The amplitude before the
application of KCL was taken as 100%. Change
in amplitude was plotted against the time.
Results were expressed as mean + SEM.
Significant difference from control values was
found at 14 and 15 minutes after application
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Figure 12 are the data of A compound actior
potentials of 6 frog sciatic nerve treated
with 20 mM KCL in isotonic Ringer solution
for 15 minutes and was subsequently washed
with Ringer solution for 15 minutes.
Conduction velocity was plotted against the
time. Results were expressed as mean± SEM.
Significant difference from contorl values was
found at 14 and 15 minutes after the
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Figure 13 are the data of A compound action
potentials of 6 frog sciatic nerves treated
with 20 mM KCL in isotonic. Ringer solution
for 15 minutes and was subsequently washed
with Ringer solution. The conduction velocity
before the application of KCL was taken as 100
%. Change in conduction velocity was plotted
against the time. Results were expressed as
mean± SEM. Significant difference from
contorl values was found at 14 and 15 minutes.














Figure 14 In vitro study of action potential
in frog sciatic nerve, original recording of
the action potential with exposure to 20 mM
KCL in isotonic Ringer solution for 15
minutes. The nerve was subsequently washed
with Ringer solution to show the gradual
return of the action potential. Conductive


























There was significant difference from control in
change of amplitude and conduction velocity at 14 and
15 minutes after the application of potassium
chloride. (p 0.05). No significant difference was
found in change of amplitude and conduction velocity
before and the application of neomycin (p 0.05). No
significant difference was found in change of amplitude
and conduction velocity with time in the control group.
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2.2 RAT VENTROLATERAL TAIL NERVE
A COMPOUND ACTION POTENTIAL:-
Table 12 lists the minimum, maximum, mean and
standard deviation of the potential from ventrolateral
tail nerves of 6 rats. Stimulation was given every 5
minutes. The potential was monitored for at least 15
minutes before the middle chamber was infused with
neomycin solution. The change in amplitude was plotted
against the time. Figure 15 represents the change in
amplitude with time. Results were expressed as mean+
SEM. The mean value before the application of neomycin
solution was 20.73+ 1.25 uV and at the end of the
treatment, the mean value was 22.12 +2.98 uV. There was
no significant difference between the change in
amplitude with time (p s 0.05). When the value obtained
before the start of the neomycin treatment was taken as
100%, the change in amplitude with time is shown in
figure 16.
CONDUCTION VELOCITIES
Table 13 lists the minimum, maximum, mean and
standard deviation of the conduction velocities from
ventrolateral tail nerves of 6 rats. The change in
conduction velocity was plotted against time. Figure 17
represents the change in conduction velocity with
time. Results were expressed as mean+ SEM. The mean
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value at the beginning of the'treatment was 24.7 +0.8
m/s and at the end of the treatment, the mean value was
23.5+ 0.8 m/s. There was no significant difference
between the change in conduction velocity with time (p
0.05). When the value obtained before the start of
the neomycin treatment was taken as 100%, the change in
conduction velocity with time is shown in figure 18.
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10-MM POTASSIUM SULPHATE IN.ISOTONIC KREBS SOLUTION
AMPLITUDE OF A POTENTIAL
Table 12 lists the minimum, maximum, mean and
standard deviation of the potential from ventrolateral
tail nerve of 6 rats. Stimulation was given every 5
minutes for one hour. The change in amplitude was
plotted against time. Figure 19 represents the change
in amplitude with time. Results were expressed as mean
+SEM. The mean value at the beginning of the treatment
was 23.94 +2.97 uV. There was mark decreased in the
amplitude with respect to time upon exposure to 10 mM
K2SO4 Krebs solution. Complete blockade of A potential
was found from 5 minutes onward. When the rat-tail was
flushed with Krebs solution, there was gradual return
of the A potential. At 10 minutes,the mean value was
20.42 +2.43 uv. Significant difference was found at 5
and 10 minutes after the exposure to 10 mM K2SO4 Krebs
solution (p 0.05). When the value obtained before the
start of potassium sulphate infusion was taken as 100%,
the change in amplitude with time is shown in figure
20
CONDUCTION VELOCITIES
Table 13 lists the minimum, maximum, mean and
standard deviation of the conduction velocities from
ventrolateral tail nerve of 6 rats. The change in
conduction velocity was plotted against time. Figure 21
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represents the change in conduction with time. Results
were expressed as mean+ SEM. The mean value at the
beginning of the treatment was 24.37+ 1.84 m/s.
Complete block of the potential was found from 5
minutes after exposure to 10 mM K2SO4 onward. When the
rat-tail was flushed with Krebs solution, conduction
velocity gradually increase. At 10 minutes, the mean
conduction velocities was 21.94 +2.01 m/s. Which was
89.13+ 8.37% of the original value. Significant
difference between the change in conduction velocities
with found at 5 and 10 minutes after exposure to 10 mM
K2SO4 solution (p 0.05). When the value obtained
before the start of the potassium sulphate infusion was
taken as 100%, the change in conduction velocity is
shown in figure 22.
The original recording of the A compound action
potential on the effect of neomycin and 10 mM K2SO4 in
Krebs solution is shown in figure 23.
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0.0
10575 906030 450 15
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Figure 15 are the data of the a compound
action potentials in 6 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution.
Average potential was plotted against the
time. Results were expressed as mean +SEM. No
significant difference from control values was
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Figure 16 are* the data of the A compound
action potentials in 6 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution. The
amplitude before the-application of neomycin
was taken as 100%. Change in amplitude was
plotted against the time. Results were
expressed as mean+ SEM. No significant
difference from control values was found after
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Figure 19 are the data of the A compound
action potentials in 6 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs
solution. Complete blockade was shown from 5
minutes onward after the application of K2SO4
solution. The nerve was subsequently washed
with Krebs solution. Amplitude was plotted
against the time. Results were expressed as
mean +SEM. Significant difference from control
values was found at 5 and 10 minutes after the
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Figure 20 are the data of the A compound
action potentials in 6 rat ventrolateral tail
nerve treated with 10 mM K2SO4 Krebs solution.
Complete blockade was shown from 5 minutes
onward. The nerve was subsequently washed with
Krebs solution. The amplitude before the
application of K2SO4 was taken as 100%. Change
in amplitude was plotted against the time.
Results were expressed as mean ± SEM.
Significant difference from control values was
found at 5 and 10 minutes after the exposure
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Figure 17 are the data of the A compound
action potentials in 6 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution.
Conduction velocity was plotted against the
time. Results were expressed as mean +SEM. No
significant difference from control values was





A COMPOUND ACTION POTENTIAL






Neomycin started Wash with Krebs solution
0
0 15 30 45 60 75 90 105
TIME (minutes)
Figure 18 are the data of the A compound
action potentials in 6 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was. then
subsequently washed with Krebs. solution. The
conduction velocity before the application of
neomycin solution was taken as 100 %. Change
in conduction velocity was plotted against the
time. Results were expressed as mean +SEM. No
significant difference from contol values was
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Figure 21 are the data of the A compound
action potentials in 6 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs
solution. The nerve was subsequently washed
with Krebs solution. Conduction velocity was
plotted against the time. Results were
expressed as mean +SEM. Significant difference
from control values was found at 5 and 10
minutes after the exposure to 10 mM K2SO4
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Figure 22 are the data of the A compouziu
action potentials in 6 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs
solution. The nerve was subsequently washed
with Krebs solution. The conduction velocity
before the application of K2SO4 was taken as
100%. Change in. conduction velocity was
plotted against the time. Results were
expressed as mean ±SEM. Significant difference
from control values was found at 5 and 10
minutes after the exposure to 10 mM K2SO4






RAT VENTROLATERAL TAIL NERVE







Figure 23 In vivo study of A compound action potential in
rat ventrolateral tail nerve, original recording of the
action potential with exposure to 5.7 mM neomycin solution
in Krebs solution for 60 minutes, washed with Krebs solution
for 30 minutes and subsequently expose with 10 mM K2S0i to
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There was significant difference in change of
amplitudes and conduction velocities from control at 5
and 10 minutes after expsoure to 10 mM K2SO4 in Krebs
solution (p<0.05). No significant difference was
found in change in amplitude and conduction velocity
before and after the infusion of neomycin in Krebs
solution.
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2.3 RAT VENTROLATERAL TAIL NERVE:- C COMPOUND ACTION
POTENTIAL
AMPLITUDES OF C POTENTIAL:-
Table 14 lists the minimum, maximum, mean and
standard deviation of the C potentials from
ventrolateral tail nerves of 9 rats. Integrated
potential was computed. The change in amplitude with
time was plotted. Figure 24 represents the-. change in
amplitudes with time. Results were expressed as mean±
SEM. There was no linear relationship between change in
potential with time. The mean value before the start of
neomycin infusion was 4.02 +0.48 uV The mean value at
the end of the treatment was 4.63 +0.63 uV. No apparent
change was found when the nerve was washed with Krebs
solution. When the' values obtained before the start of
the neomycin infusion was 100%, the change in
amplitudes are shown in figure 25.
CONDUCTION VELOCITIES
Table 15 lists the minimum, maximum, mean and
standard deviation of the conduction velocities from
ventrolateral tail nerves of 9 rats. Conduction
velocities of the fastest and the slowest C potential
were recorded. The change in conduction velocities with
time was plotted. Figure 26 represents the change in
conduction velocities with time. Results were expressed
as mean SEM. The mean value before the infusion of
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neomycin solution were 0.89 +0.04 and 0.54 +0.02 m/s
respectively. At the end of the treatment, the mean
value were 0.96 +0.07 and 0.64 +0.04 m/s respectively.
There were no significant difference between change in
conduction velocities with time (p>0.05). No apparent
change was found when the nerve was washed with Krebs
solution. When the values obtained before the start
of the neomycin infusion was 100%, the change in
conduction velocities are shown in figure 27.
10 mM POTASSIUM SULPHATE KREBS SOLUTION
AMPLITUDES OF C POTENTIAL
Table 14 lists the minimum, maximum, mean and
standard deviation of the amplitudes from
ventrolateral tail nerves of 9 rats. Integrated
potential was computed. The change in amplitudes with
the time was plotted. Figure 28 represents the change
in amplitudes with time. Results were expressed as mean
SEM. The mean value before the infusion of 10 mM K2SO4
was 4.41 0.55 uV. At the end of the treatment, the
mean values was 0.80 0.21 uV. Significant difference
in change of amplitude from control was found at 10
and 15 minutes after exposure to 10 mM K2SO4 Krebs
solution (p 0.05). When the nerve was flushed with
Krebs solution, there were gradual return of the
amplitude of the potential. The mean value at the end
of the treatment were 3.18 0.55 uV. When the value
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obtained before the start of potassium sulphate
infusion was taken as 100%, the change in potentials
are shown in figure 29.
CONDUCTION VELOCITIES
Table 15 lists the minimum, maximum, mean and
standard deviation of the conduction velocities from
ventrolateral tail nerve of 9 rats. Conduction
velocities of the fastest and slowest C potential were
recorded. Figure 30 represents the change in conduction
velocities with time. Results were expressed as mean+
SEM. The mean values at the beginning of the treatment
were 0.95 +0.04 and 0.65 +0.05 m/s respectively. At the
end of the 10 mM K2SO4 treatment, the mean values were
0.45 +0.07 and 0.36 ±0.05 m/s respectively. Significant
difference from control was found at 15 minutes after
exposure to 10 mM K2SO4 Krebs solution (p 0.05). When
the nerve was flushed with Krebs solution, there were
gradual return of the conduction velocities. At 15
minutes, the mean values were 0..89 +0.07 and 0.60 +0.03
m/s respectively. When the values obtained before the
start of the potassium sulphate were taken as 100%, the
change in conduction velocities are shown in figure 31.
Figure 32 and 33 are two sets of original recordings
of the C compound action potential on the effect of
neomycin and 10 mM K2SO4 Krebs solution.
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Neomycin started Wash with Krebs solution
0.0
0 15 30 45 60 75 90 105
TIME (minutes)
Figure 24 are the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution.
Average potential was plotted against the
time. Results were expressed as mean +SEM. No
significant difference from control values was
found after the exposure of neomycin solution
(P>0.05).
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Wash with Krebs solutionNeomycin started
0
0 30 7515 45 60 10590
TIME (minutes)
Figure 25 are the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution. The
amplitude before the application of neomycin
was taken as 100%. Change in amplitude was
plotted against the time. Results were
expressed as mean + SEM. No significant
difference from control values was found
after the exposure to neomycin solution (P >
0.05).
CHANGESINMPLITUDE(%)
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K2SO4 started Wash with Krebs solution
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Figure 28 are the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs
solution for 15 minutes. The nerve was
subsequently washed with Krebs solution.
Amplitude was plotted against the time.
Results were expressed as mean + SEM.
Significant difference from control values was
found at 10 and 15 minutes after the exposure
to 10 mM K2SO4 Krebs solution (P<0.05).
AMPLITUDE
(uV)
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Figure 29 are the data of the A compound
action potentials in 9 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs solution
for 15 minutes. The nerve was subsequently
washed with Krebs solution. The amplitude
before the application of K2SO4 was taken as
100%. Change in amplitude was plotted against
the time. Results were expressed as mean ±SEM.
Significant difference from control values was
found at 10 and 15 minutes after the exposure







C COMPOUND ACTION POTENTIAL
RAT VENTROLATERAL TAIL NERVE
DATA OF CONDUCTION VELOCITY
TIME FASTEST CHANGE OF SLOWEST CHANGE OF
in minutes C POTENTIAL CONDUCTION C POTENTIAL CONDUCTION
in m/s in m/s VELOCITY(%)VELCOITY(%)
OF CONTROL OF CONTROL
0
Minimum
.71 89.29 .42 79.08
Maximum 1.18 115.04 .72 132.09
Mean .91 101.91 .55 101.04
StdDev .16 7.81 .11 15.17
N 9 9 9 9
5
Minimum .71 87.27 .43 87.70
Maximum 1.12 109.88 .80 147.75
Mean .88 98.76 .57 104.35
StdDev .15 7.12 .12 17.35
N 9 9 9 9
10
.72Minimum 87.68 .47 95.19
108.83Maximum 1.07 .81 149.19
99.75.89 .57Mean 105.91
7.39.13 .11StdDev 16.72
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Maximum 1.20 116.16 .96 176.62
Mean .92 103.74 .65 121.11
StdDev .17 11.48 .15 30.02

































C COMPOUND ACTION POTENTIAL
RAT VENTROLATERAL TAIL NERVE
DATA OF CONDUCTION VELOCITY
FASTEST CHANGE OF SLOWEST CHANGE OF
TIME
C POTENTIAL CONDUCTION C POTENTIAL CONDUCTION
in m/s in m/s VELOCITY(%)VELCOITY(%
OF CONTROL OF CONTROL
50 (35)
Minimum .81 93.58 .51 80.85
Maximum 1.14 119.20 .81 150.16
Mean .94 106.49 .60 111.95
StdDev .12 9.10 .11 22.81
N 9 9 9 9
55 (40)
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OF CONTROL OF CONTROL
75 (60) wash with Krebs solution
Minimum .75 .5280.44 78.67
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Wash With Krebs solutionNeomycin started
0.00
30 90 10560 750 4515
TIME (minutes)
Figure 26 are the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution. The
fastest and slowest C potential were recorded
(0 and 0 respectively). Conduction velocities
were plotted against the time. Results were
expressed as mean + SEM. No significant
difference from control values was found
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Neomycin started Wash with Krebs solution
0
300 15 45 60 9075 105
TIME (minutes)
Figure 27 are the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves. 5.7 mM neomycin solution was started
from 15 minutes onward. Whole treatment period
was 60 minutes. The nerve was then
subsequently washed with Krebs solution. The
fastest and slowest C potential were recorded
(0 and 0 respectively). The conduction
velocities before the application of neomycin
solution were taken as 100 %. Changes in
conduction velocity were plotted against the
time. Results were expressed as mean +SEM. No
significant difference from control values was
found after the exposure to neomycin solution
(P > 0.05).
CHANGEINCO DUCTIONVELO I IES(%)
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K2S04 started Wash With Krebs solution
0.00
90 95 100 105 110 115 120 125 130 135
TIME (minutes)
Figure 30 were the data of the C compound
action potentials in 9 rat ventrolateral tail
nerves treated with 10 mM K2SO4 Krebs solution
for 15 minutes. The nerve was subsequently
washed with Krebs solution. The fastest and
slowest C potential were recorded (0 and
respectively). Conduction velocities were
plotted against the time. Results were
expressed as mean ±SEM. Significant difference
from control values was found at 10 and 15
minutes after the exposure to 10 mM K2SO4
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Figure 31 are the data of the C compounc
action potentials in 9 rat ventrolateral tail
solution for 15 minutes. The nerve was
subsequently washed with Krebs solution. The
fastest and slowest C potential were recorded
(0 and 6 respectively). The conduction
velocities before the application of K2SO4
solution were taken as 100 %. Change in
conduction velocities were plotted against the
time. Results were expressed as mean +SEM.
Significant difference from control values was
found at 10 and 15 minutes after the exposure
to 10 mM K2SO4 Krebs solution (P <0.05).














Figure 32 In vivo study of C compound action potential in
rat ventrolateral tail nerve, original recording of the
action potential with exposure on 5.7 mM neomycin solution
in Krebs solution for 60 minutes, washed with Krebs solution
for 30 minutes and subsequent expusure to-- 10 mM K2SO4 to
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Figure 33 In vivo study of C compound action potential in
rat ventrolateral tail nerve, original recording of the
action potential with exposure on 5.7 mM neamycin solution
in Krebs solution for 60 minutes, washed with Krebs solution
for 30 minutes and subsequent exposure to- 10 mM K2SO4 to

































Significant difference in change of
amplitudes and conduction velocities from control was
found at 10, 15 minutes and 15 minutes respectively
after expsoure to 10 mM K2SO4 Krebs solution (p
0.05). No significant difference was found in change in
amplitude and conduction velocity before and after the




Since the isolation of neomycin from Streptomyces
fradiae by Waksman and Lechevalier in 1949, neomycin has
been used successfully in treating infection caused by
gram-negative bacteria. Beside the therapeutic
significance, the aminoglycoside is also well known of
for ototoxicity, nephrotoxicity, neuromuscular blockade
effect and modulation of the normal function of several
excitable tissues (Schtbeci and Schacht, 1977 Schacht,
1986 Hawkins, 1976 Baumann, Hamann and Leung,1988).
Recently, streptomycin has been used successfully in the
treatment of idiopathic trigeminal neuralgia (Sokolovic,
Todorovic, Stajeic and Petrovic 1986). From the works of
the above authors, the aminoglycoside may act diversely
on cellular mechanisms. The aim of the present study is
to investigate the possible effects of neomycin on the
conduction in nerve fibres. Transmission of information
or signal carrying in nerve fibres is effected through
the propagation of action potentials.
The action potential serves to conduct an
electrical impulse with undiminished strength along the
length of the nerve fibre. Propagation of the action
potential occurs by the mechanism of depolarization and
re-polarization. When the areas on either side of the
depolarized region reach the threshold, an action
potential will be generated. By local current flows, the
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areas adjacent to these will be brought to threshold
and will in turn generate an action potential. Through
this process, action potentials propagate over the
whole length of nerve fibres in the same shape and
size. There are four clearly defined phases in an action
potential. The rising phase (in which the membrane
potential with respect to the extracellular space
becomes more positive), the peak, the falling phase( in
which the membrane potential returns to its original
negativity) and the underswing phase( in which the
membrane potential is actually more negative than under
resting conditions). The duration of the action
potential in nerve fibres is only a few milliseconds.
In the preliminary series of experiment on frog,
sciatic nerve was used. It was because the nerve itself
was relatively easy to dissect, and the results can be
compared with those from other workers like Sokoll and
Diecke (1969) who had carried out similar experiments
with streptomycin.
The original hypothesis was that acute exposure to
neomycin may have an acute effect on the nerve fibre.
Frequent stimulation and monitoring of the nervous
impulses was necessary. Therefore, stimulation was given
every minute for 30 minutes. The preliminary series of
the experiment did not produce any positive result. A
longer duration of exposure may be necessary before
neomycin can exert its effect on the nerve. Exposure of
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the nerve for 1 hour was performed on the rat
ventrolateral tail nerve. Stimulation was given every 5
minutes.
Acute exposure of myelineated nerve fibres to
neomycin with concentration of 350 mg/ 1 to 1400 mg/ l on
the rabbit sural nerve had been studied by Chan et al.
(1985). There was no apparent acute functional
impairment of nervous conduction. A higher concentration
may be necessary to reveal the effects of neomycin on
the nerve fibres. A concentration of 3500 mg/l was thus
used in the present experiment.
1.1 CONDUCTION VELOCITIES OF FROG SCIATIC NERVE AND RAT-
TAIL NERVE
In the studies of generation and propagation of
nervous impulse in nerve fibres, amplitudes and the
conduction velocities of the action potential are two
parameters that have to be measured. The measurement of
conduction velocity is subject to some degree of
uncertainty. As a measure of speed, conduction velocity
is derived from the estimation of. time and distance.
Hence factors affecting either temporal or spatial
resolution will contribute to the uncertainty of the
conduction velocity measurement. The quantifiable
factors include the minimum sampling time of the
averaging technique and the background noise. Both of
these will affect conduction latency resolution. The
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finite resolution and subjective placement of the
caliper between the stimulating and recording electrode
would contribute to the error in the measurement of
conductive distance (Gordon, Hamm, Enoka, Reinking,
Windhorst and Stuart. 1987).
It has been well established that the conduction
velocity of the nervous impulses decreases with the fall
of the body/ surrounding temperature (Hodgkin and Katz
1949 Paintal 1965). The conduction velocity in
amphibians e.g. the frog will be far slower than in
mammalian species. The mean conduction velocity of the A
compound action potential of frog sciatic nerve obtained
in here are comparable with other workers like Meyer and
Hegmann (1971).
The rat tail occupies about 12.8% of the
surface area for a rat weight 350g (Lyzak and Hunter,
1987). It is the main site of heat dissipation during
body heating. Heat dissipation through the tail occurs
largely through increase in rat tail blood flow and
vasodilation in the rat-tail accompanying heating occurs
solely via reduction in sympathetic vasoconstrictor
nerve activity (O'Leary, Johnson and Taylor, 1985). The
rat tail temperature in resting state is far below the
body core temperature. Therefore, maintenance of body
temperature of the rat tail is important to get a
comparable conduction velocity in the nervous impulse.
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It is achieved by maintaining the core temperature of
the rat by putting the rat on a thermostatically
controlled electric blanket (Bioscience CFP-8185). To
maintain the rat tail temperature, bathing the rat tail
in paraffin oil had been used by some workers (Miyoshi
and Goto, 1973 Ono, Takeuchi and Hisanaga, 1979). This
method only allows transcutaneous stimulation of the
nerve fibres. The present experiments make use of a U-
shaped glass tube to embed the rat tail allows the
maintenance of the rat tail temperature as well as
direct stimulation and recording of the nerve fibres.
Birren and Wall (1956) reported that motor
conduction velocities increase at a rate of about 1.2
m/ s per degree between 20 °C and 40 °C in vitro
experiments on rat sciatic nerve. Miyoshi and Goto
(1973) gave more direct measurements of the rat-tail
nerve. They estimated that the conduction velocity of
rat-tail increases linearly at a rate of about 1.3 m/s
per degree between 24 °C and 42 °C. They also stated
that the conduction velocity increases during growth to
about 300 days. In in vitro experiments, they found that
when the mean subcutaneous temperature was 36.4 +0.7 C,
the mean conduction' velocity of the A potential in
Sprague-Dawley rat was 34.8 +3.2 m/s. in 100 day old
rats. Taken into consideration of the mean temperature
in the present studies, the corresponding conduction
velocity should be about 30 m/s. One factor that may
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account for the slower velocities may be the damage of
the capillaries which supply the nerve fibres. As a
result, the vascular supplies which maintain the
temperature of the nerve fibre is disturbed. In
addition, the temperature recorded subcutaneously may
not actually correspond to the temperature at the
recording site. Taken all these points into
consideration, the results obtained here correspond well
with the studies of Miyoshi and Goto (1973) and Ono and
his coworkers (1979).
Conduction velocities of the fastest and slowest C
potential in the whole spectrum of C potential were
selected in the present experiment. In the present
experiment, conductive distance of about 8-10 cm. was
used frequently. The amplitudes of the C potentials
showed several volleys which were dispersed quite
widely. The latent period was from the range of 100 to
200 ms for a conductive distance of 8-10 cm. The
conduction velocities of the C potential recorded here
are well below 1.5 m/s which agrees well with
classification by Gasser (Gasser, 1950).
1.2 AMPLITUDES OF THE ACTION POTENTIAL
The amplitude of the compound action potential
depends on a number of factors including the distance
between the neural membrane (axolemma) and the recording
electrodes, the distance between the two electrodes and
168
the electrical properties of the interposing, non-neural
tissue. The amplitudes diminish with increasing distance
from the axis of the nerve. This radial dependence was
of exponential decay with increasing distance from the
nerve (Plonsy and Fleming 1969). The shape of the
compound action potential will also be affected by the
diversity of conduction velocities in different nerve
fibres. This will be more apparent when the conduction
distance decreased.
In the studies of the compound action potential of
the whole nerve or strands of nerve fibres, the whole
spectrum of the A potential falls within the same peak
in the frog sciatic nerve. Peak potential is selected to
represent the amplitude of the whole A potential. In the
rat ventrolateral tail nerve, the A and C potential
spread out widely. There will be drawback if selection
of peak potentials are used to represent the whole range
of the action potential. The decrease in one peak may be
compensated by increase in amplitude in other peak
potentials which had not been monitored. As a result of
this, the whole algebraic sum of the potentials may be
the same but the selected peak potential may be changed
tremendously. The data analysis program developed for
the present experiment help to solve this problem. The
whole range of the A or C potential was first located on
screen by the.cursor which gave an accuracy of 0.1 ms.
Full wave rectification was performed. Integration of
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the range divided by the interval gave the average
amplitude of A and C potential respectively. The program
also provided automatic determination of the baseline or
zero line level which was done by sampling the ground
noise level before the stimulation.
1.3 EFFECTS OF NEOMYCIN ON THE NERVE FIBRES
It has been well documentated that the toxicities
of the aminoglycosides include neuromuscular blockade
(Adams. and Matthew, 1973 Singh, Harvey and Marshall,
1978 Rosayro and Healy, 1978 Fickers, 1983),
nephrotoxicity (Schtbeci and Schact, 1977 Hagiwara et
al., 1988), ototoxicity (Hawkins, 1976) and reduction of
responsiveness in touch corpuscles (Baumann, Hamann and
Leung, 1986). As far as the neuromuscular blockade is
concerned, the basic elements of normal neuromuscular
transmission that can be affected by antibiotics are 1.
action potential transmission in the motor nerve and
motor nerve terminal 2. the process of synthesis,
mobilization and release of acetylcholine from the nerve
terminal 3. the integrity of the post-synaptic
cholinergic receptor 4. action potential generation
and propagation in the muscle membrane 5. normal
excitation-contraction coupling in the muscles.
The neuromuscular blockade by neomycin was
associated with a large significant decrease in evoked
release of acetylcholine and with a smaller but still
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significant decrease in post-junctional receptor
sensitivity and spontaneous release (Adams and Matthew,
1973 Wright and Collier, 1977). The reduced transmitter
release is by a mechanism similar to that of magnesium
ions which involves a competition for calcium ions
binding sites on the nerve terminal (Prado et al.,
1978).
Little knowledge is available about the effect of
neomycin on the generation and propagation of the action
potential in the nerve fibers. From the pathological
findings due to aminoglycoside ototoxicity in man, it
was concluded that the nerve fibres become affected only
when the hair cells were missing. Nerve fibre
degeneration was secondary to hair cell degeneration.
The distal processes of the first order neurons tend to
degenerate earlier than the proximal processes. However,
many of the human cases stated in here are long
standing deafness which is quite different from the
acute exposure (Hurizing and de Groot, 1987). In
clinical studies, aminoglycoside induced peripheral
nerve symptoms have hot been reported. However,
peripheral nerve symptoms which include paraesthesia,
motor weakness or sensory impairment had been associated
with the use of the penicillins, sulfonamides,
chlorophenicol, colestin, metronidazole, isoniazid,
ethionamide and dapsoma (Snavely and Hodges, 1984).
Streptomycin is the only aminoglycosides in which
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its effect on the conduction of the action potential had
been study. Sokoll and Diecke (1969) investigated the
effect of streptomycin on the A potential of frog
sciatic nerve conduction. A local anesthetic-like action
was observed. In their studies, 400 mg/1 of streptomycin
was found to resemble the effect of 0.002% of lidocaine
or 0.003% of procaine. The effect included depression of
action potential, conduction velocity and slope of
depolarization. The depression of action potentials
ranged from 10 to 25% when the concentration of
streptomycin increased from 400 to 3200 mg/l and the
slope of depolarization was from 87 to 67% of the
original value. The decrease in conduction velocity
averaged 10% in a concentration of 400 mg/l. Little
change was observed when the concentration decreased to
50 mg/l. The effect was due to the changes of the
sodium conductance of nerve during excitation. Since the
rate of change of the membrane voltage during excitation
was a function of the sodium current or sodium
conductance, a decrease in sodium conductance would
reduce the slope of the action potential and the size of
the action potential. The peak membrane potential during
excitation will not*approach the sodium equilibrium
potential as closely as with normal sodium conductance.
The decreased conduction velocity was a direct result of
the reduced slope of the rising phase of the action
potential. These changes were very rapid in onset and
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readily reversible if the exposure was of short
duration. However, the authors failed to mention the
of the recovery in their studies. Furthermore the number
of animals involved had not been reported and no
statistical test had been presented.
One of the probable mechanism that neomycin may
affect the nervous conduction is by changing the
permeability of Na+, K+ and Ca2+ ions which associate
with the action potential in the nerve conduction. The
rising phase of the action potential occurs as a result
of an increased membrane permeability toward Na+ which
causes the membrane potential to move toward the
equilibrium potential for Na+. Within a few milliseconds
after the initiation of the action potential, the
permeability of K+ begins to rise, an event that
counteracts the increasing permeability toward Na+. As a
result, the membrane potential begins to return toward
resting condition. The permeability to Na+ again returns
to resting value and the falling phase occurs. The
refractoriness accompanying the action potential is
determined by the inactivation of the sodium and an
increase of potassium membrane permeability. Any action
or mechanism that would affect the permeability of Na+
and K+ would result in change in amplitude as well as
the conduction of the nervous impulse.
Molecular models for impulse initiation and
propagation had been proposed by many investigators. It
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is generally accepted that the ionic channels or pores
that underlie membrane permeability are macromolecules.
They are most probably single proteins or protein
complexes that form aqueous pores within the lipid
bilayer of the membrane to allow passage of a given
ionic species. The outer portion of the channel 'which
faces the extracellular environment most probably have a
selectivity filter of unknown composition that can
recognize specific cations or anions. Within the channel
itself, some form of sensor factor is present that can
recognize the electric field surrounding the ionic pore
and can rapidly induce a conformational change in the
macromolecule, including the portion that is responsible
for the gating of ions.
Na+/K+- ATPase is an enzyme believed to be present
in all living cell membranes. The primary function of
the enzyme is to maintain the transport of cations so
that a proper ionic gradient inside and outside of the
cells are established. It has been suggested that it is
one of the macromolecular constituents of nervous tissue
that plays a critical role in the function of the
nervous system. The Na+-K+ pump is especially active in
the axolemma immediately after the action potential. Its
presence is essential for the maintenance of both the
Na+ and K+ concentration gradients across the axolemma.
During the action potential, a small amount of Na+ leaks
into and a small amount of K+ leaks out of the neuronal
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cytoplasm. Although relatively insignificant after one
or two potentials, an enormous alteration of the
intracellular Na+ and K+ concentration would ensue if
.not constantly corrected by the Na+-K+ pump.
If neomycin acts directly on the nervous
conduction, a local anesthetic-like action should be
demonstrated as was reported by Soicoll and Diecke
(1969). The blocking effect of the local anesthetic
drugs are through the blockade of the sodium current and
to a lesser extent the potassium current. The mechanism
underlying the blockade of sodium current is quite
different from the action of tetrodotoxin. They are
active when applied on the internal surface of the
membrane, or when applied externally, they can diffuse
.through the membrane and reach the receptor site within
the sodium channel because of their high lipid
solubility. The anesthetic molecule gains access to the
receptor when both the inactivation and activation gates
are open. The local anesthetic receptor interaction
produce conformational change of the channel proteins
and consequently, the probability of closure of the
inactivation gate is enhanced. The binding of the
molecule is stronger when the sodium channel is in the
.inactivated state. As a result, the flow of sodium ions
through the channel is prevented (Khodorov, 1981
Mitolo-Chieppa and Carratu 1983).
However, the result obtained here does not
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parallel with the study by Sokoll and Diecke (1969),
the concentration of neomycin used in here (3500 mg/1)
is much higher than their study. If a dose-dependent
effect is resulted, the amplitude of the action
potential should decrease by more than 25% and the
conduction velocities should decreased by more than 10%
in the A potential. The occurrence of the depression
should be quite rapid in onset and readily reversible.
However, the present study does not reveal any
significant changes in the amplitudes and the conduction
velocities. The conduction velocities recorded were
steady all the time. It did not show any change in
conduction velocities with time.
The difference in action of neomycin with the local
anesthetic may be the water soluble polycationic
aminoglycoside can not gain access into the hydrophobic
receptor site of the channel. From the molecular point
of view, the ionic channels are composed of integral
proteins, hydrophobic segment situated deeply in the
lipid interior of the membrane and hydrophilic segments
protruding out of membrane plane into the water phase.
Neomycin must diffuse into the lipid membrane matrix to
reach-the site of action.
Another probable mechanism by which neomycin may
act on the nerve fibre is by disturbing the metabolism
of the nhosphoinositides in the nervous system. The
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inositol-lipid pathway had been proposed as another
second messenger system. In the nervous system,
hydrolysis of inositol lipids generates two second
messengers, IP3 and diacylglycerol which regulate the
membrane potential in tail motor neuron of Aplysia
(Sawada, Cleary and Byrne 1989).
There is clear evidence that neomycin
interferes with the hydrolysis of the phosphoinositides
into inositide trisphosphate. Neomycin occupies calcium
binding sites provided by negatively charged phosphate
groups of the polyphosphoinositides in the membrane. The
neomycin-bound phosphoinositides is a poor substrate for
the dephosphorylating enzyme and the dephosphorylation,
phosphorylation cycle is disturbed (Schacht, 1976). Next
question is whether the metabolism of the
phosphoinositides affect the conduction of the nervous
impulse.
Polyphosphoinositides are localized predominately
in myelinated nerves (Eichberg and Dawson, 1965).
Physical and chemical. properties of phosphoinositides
indicate that these lipids may be capable of controlling
ion permeability in membranes. Phosphoinositides e.g.
inositol trisphosphate complexes interact readily with
divalent metal ions such as calcium and magnesium. In
the absence of divalent metal ions, these lipids are
largely water soluble but become water insoluble upon
the addition of metal ions. Phosphoinositides complexes
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interact readily with a variety of proteins forming in
most cases water soluble complexes. (Hendrickson and
Reinertsen,1971)
Hawthorne and Kai in 1970 suggested that the
hydrolysis of inositide trisphosphate to inositide
bisphosphate or monophosphate in the nerve axonal
membrane results in a release of bound Ca2+ ions which
opens up pores with increased permeability to monovalent
ions. In Hendrickson and Reinertsen studies, conversion
of triphosphate to bisphosphate would result in a
release of 70% of bound Ca2+ and a 25% decrease in
ligand charge. The net' increase in positivity of the
membrane would favor an increase in K+ over Na+
permeability implicating this mechanism in the falling
phase of the action potential. On the other hand,
changes in membrane structure might lead to increase
negativity at the channel sites despite an overall
increase in positivity of the membrane. This mechanism
would favor an increase in Na+ over K+ permeability as
in the rising phase of the action potential. Since in
the absence of divalent metal ions, phosphoinositides or
phosphoinositide proteins complexes are largely water
soluble, hydrophilic pores of increased local negativity
could be formed under these conditions. For monovalent
ions in biological systems, pore charge is of even
greater importance in control of selective ion
permeability.
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High' metabolic activity of the inositide had been
shown both in nerve cell bodies and highly in poorly
myelineated nerve fibres. White and co-workers (1974)
demonstrated that electrical stimulation results in
increased incorporation of phosphate into inositol
trisphosphate in poorly myelineated nerve fibres. In
vagus nerve, it gives the most clear cut result as the
passage of each impulse in such fibres is associated
with much larger ion movement to per unit volume than in
myelineated fibres. Tetrodotoxin which selectively
blocks the outside of the channels through which sodium
ions normally flow during the rising phase of the action
potential has no effect on phospholipid labeling in
vagus or phrenic nerve. It appears to bind to
cholesterol rather than other membrane lipids as
measured by the monolayers technique and does not affect
active sodium transport at the concentration normally
.used. Salway and Hughes (1972) suggested that
polyphosphoinositides are not involved in the control of
the sodium channel or else tetrodotoxin would be
expected to produce a decrease of 32P incorporation into
'these lipids, or the changes of the
polyphosphoinositides' may be taken place at the inner
end of the sodium channel where ATP is available and
external tetrodotoxin would have no effect.
. Ouabain which can inhibit Na+-K+ ATPase in axoleinma
and plasma membranes of Schwann cells, at concentrations
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which block the action potential in vagus nerve, had no
effect on the triphosphate or bisphosphate. Increased
abeling of phospholipid was found. (White, Schellhase
and Hawthorne, 1974). On the basis of work with the iris
and other tissues, Akhtar and Abdel-Latif (1982)
postulated that the rephosphorylation of 1,2
diacylglycerol into phosphatidic acid and
phosphoinositides could be associated with Na+ outflux
via the Na+-pump mechanism.
In clinical conditions, the lack of inositol. and
resulting metabolic disturbances may be responsible for
the nerve conduction defects in diabetes (Winegrad,
1983). Incubation of isolated sciatic nerve of diabetic
rats in a medium containing [33P] orthophosphate result
in decrease in labeling of phosphatidylinositol and
substantial changes in the labeling pattern• of
phosphatidylinositol phosphate and bisphosphate from
that of controls. The ratio of label in these
polyphosphoinositides decreased from 2.5 for normal
myelineated nerve to about 1 for diabetic nerve and 2.8
in the poorly myelineated fibres within 45 minutes of
incubation (Natarajan et al., 1981).
These studies pose the idea that
Dolyphosphoinositides may be involved in the control of
nembrane permeability during axonal conduction.
alternation in their relative amount or turnover rates
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woula result in changes in the amplitudes of the
potential as well as the conduction velocities.
The present investigation using neomycin as a model
for the alternation in the metabolism of
phosphoinositides revealed that there is no significant
difference in the amplitude as well as the conduction
velocities in the myelineated and unmyelineated nerve
fibres. Slowing of the conduction velocity was not shown
after exposing the nerve for 60 minutes in a medium of
3500 mg/l of neomycin in Krebs solution. Flushing the
nerve with Krebs solution and continuous monitoring for
30 minutes show no apparent changes in the conduction
velocity.
There are no significant changes in the A and C
potential in tail ventrolateral tail nerve during the
application of neomycin solution. In the frog sciatic
nerve studies, there is no significant difference in the
peak potential before and after the exposure with
neomycin. The reason may be 1. the acute effect of the
neomycin may not have any apparent effect of the
phosphoinositides metabolism 2. as proposed by Salway
and Hughes (1972), the changes of the
polyphosphoinositides' may be taking place at the inner
end of the channel and neomycin cannot enter this space
3. the metabolism of the phosphoinositides is not
involved in the conduction of the nervous impulses.
Another possible mechanism that neomycin may affect
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the nervous impulses is through its competing action
with calcium ions. It had been well established that
neomycin competes with the calcium in the calc.ium
binding sites at the neuromuscular junction (Kubikowski
and Szreniawski, 1963 Prado et al 1978 Singh et al
1978). In acute exposure, it also competes with Ca 2+
for membrane binding sites on the hair cells of the
acoustico-lateralis systems that activate the
transduction process (Sand, 1975 Yanagisawa et al.
1977 Kroese and Van den Bercken, 1980 and Williams,
Zenner and Schacht, 1987). Experiments on single fibres
of squid axon, isolated fibres in the frog sciatic
nerve and node of Ranvier of frog sciatic nerve
(Frankenhaeuser, 1957 Frankenhaeuser and Hodgkin, 1957
Hille, 1968) indicated that the action potential
amplitude was smaller when [Ca]o was low and the
threshold increases with the increase of [Ca]o. The
relation between the threshold and the log [Ca]o was
nearly linear, with a slope of about 9 mV per fivefold
change in [Ca]o.
The effect of calcium ions can be explained by the
fact that calcium ions are adsorbed at the outer edge of
the membrane and thereby create an electric field inside
the membrane which adds to that provided by the resting
potential. Adsorbed calcium ions might alter the
distribution of other changed particles inside the
membrane without changing the overall potential
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difference between inside and outside (Frankenhauser and
Hodgkin, 1957). Another suggestion is based on the
similarity between the action of calcium and changes of
membrane potential. The increase in permeability occurs
because depolarization removes calcium ions from sites
or carriers in the membrane (Frankenhauser and Hodgkin,
1957). It was later suggested that Ca2+ acts on the
excitability of nerve through the electrical screening
of negative charges which are assumed to be fixed on the
external surface of the membrane (McLaughlin, Szabo and
Eisenman, 1971). This hypothesis would in the absence
of further complication, require that cations of the
same valence have essentially the same effectiveness.
Studies by Brismar (1980) showed that there is greater
effectiveness of calcium compared to other divalent
cations belonging to the same group of elements. It is
assumed that the calcium ions affect the position of Na+
permeability curve on the potential axis because of an
interaction between calcium and fixed negative charges
at the external membrane surface. D'Arrigo (1974) in an
investigation of the action of different divalent
cations on the threshold for excitation in crayfish
axons found that the'pH influences the effectiveness of
the different ions.
The results in the present study does not parallel
with the effect of Ca2+ free solution on nervous
conduction which could be expected a decrease in the
183
amplitude of the action potential. It may appear that
the effect of neomycin on the nerve fibres behaves
differently to that of the depletion of calcium ion on.
the nerve fibre.
1.5 EFFECT OF HYPERKALEMIA IN THE AMPLITUDES AND
CONDUCTION VELOCITIES OF NERVOUS IMPULSE IN THE NERVE
FIBRES
Potassium is the principal cation of all cells and
its main functions are 1. contribution to cell osmotic
pressure. 2. activation of enzymes and 3. the potential
across cell membranes.
In the resting state of the nerve cells, the steady
Na+ influx is balanced by a steady K+ efflux. The
resting potential is close to the Nernst potential of
K+. Changes in extracellular potassium concentration
results in changes in membrane potassium.
Acute elevation of plasma potassium ions will lead
to increased excitability (i.e. reduced threshold) in
nerve fibres. It had been shown by Seneviratne and his
'co-workers (Seneviratne, Peiris and Weeraswiya, 1972)
that acute elevation, (up to 8 mM) of plasma potassium
ions in cats leads to an increase in excitability of
myelinated fibres in the tibial nerves. Further increase
in the extracellular potassium ion will result in
reducing the excitability of the nerve fibres instead of
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increasing it. Huxley and Stampfli (1951), working on
singlc isolated frog myelinated fibres, demonstrated
that a depolarization conduction block was produced when
the extracellular potassium concentration was between 10
and 20 mM. Frog motor neurons are inactivated by an
extracellular potassium concentration of 12 mM in an
isolated spinal cord preparation (Matsura, Kawaguchi,
Ichiki, Sorimochi, Kataoka and Inomya, 1969). In Huxley
and Stampfli's studies, it took only 1'.second or less
for a change in bath composition to alter the resting
membrane potential. Hence in isolated single myelineated
fibre, the ion fluxes between the nodal periaxonal
spaces and the external bath equilibrate very rapidly.
Krnjeviv (1954) noted that desheathed frog sciatic
nerves were blocked by 120 and 60 mM external potassium
concentration in about 25 and 55 seconds respectively.
The blocking time in the present experiment is of
the order of several minutes which is quite comparable
to the study of Weerasuriya (1987) who showed an average
blocking time of 7.9+ 0.3 minutes. The difference
between 'blocking times of single fibre and that of
desheathed whole nerve may be due to the disruption of
periaxonal diffusion* barriers during the isolation of
single fibre or the presence of a significant impedence
to free diffusion of ions within the endoneurial stroma
in whole nerve. Early studies of the compound action
potential suggested that the sequence of nerve block was
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related partly to size, smaller fibres tended to be
blocked before larger fibres (Gasser and Erlanger,
1929). It was thought that the large surface/ volume
ratio of smaller axons gave the drug quicker access to
the seat of action in the protoplasm (Gasser and
Erlanger, 1929). It was however later shown that the
membrane channels rather than axoplasm are the real seat
of conduction block (Hodgkin and Huxley, 1952).and that
local anesthetics block the channels by a mechanism that
does not implicate axonal diameter.
The slower blocking effect of potassium on the C
potential in here may be due a larger larger numbers of
unmyelineated nerve fibres in the whole nerve. Langford
(1983) showed that the ratio of unmyelineated to
myelineated nerve fibre was more than 70% in cat motor,
cutaneous and articular nerves. The unmyelineated fibres
are situated more centrally. It may thus give the
endoneurial extracellular space better stability or it
may be due to the different in morphology of the
myelineated and unmyelineated nerve fibres. The Na+ and
K+ channels are predominately located in the node of
Ranvier while the ionic channels in the unmyelineated
nerve fibres spread-' widely within the nerve fibres.
Bundles of unmyelineated nerve fibres are enclosed by
the Schwann cell which gives them better stability.
Elevation of extracellular potassium concentration,
before leading to a conduction block, produces a
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decrement of the amplitude of action potential. The
decrease in height of the compound action potential,
however cannot be taken as an indicator of the
proportion of fibres that have been inactivated.
The arrangement- of the present experiment has its
own limitation. It is assumed that the action of the
neomycin is confined to the immersed portion of the
nerve fibre. The exact diffusion can only be shown by
radioactive labeling- studies or fluorescent studies to
study the diffusion rate of substance of similar
molecular weight. Since the amplitude of the A and C
potential fluctuate during the whole course of
monitoring. Unitary single nerve fibre recording may
give a better indicator in this aspect. As far as the
effect of the neomycin on the metabolism of the
phosphoinositides in the nervous tissue is concerned,
radioactive labeling may give a more direct measurement





The results from the present study indicate
that with the present experimental arrangement,
neomycin does not produce any acute functional
impairment of nervous conduction in the myelinated and
unmyelinated nerve fibres, even in the present of a
fairly high concentration (3500 mg/1). This parallel
with the finding obtained by Chan and his co-workers
(1985) in the rabbit sural nerve with lower
concentration (350 mg/l to 1400 mg/1). The mechanism of
action of neomycin on nerve fibre behaves quite
different to the neuromuscular junction in which the
aminoglycosides compete with calcium ions for the same
receptor on the nerve terminal membrane and produce
complexes that are incapable of transmitter release
(Vital-Brazil and Prado-Franceschi. 1969 Yamada et al
1986). It also works differently from the lateral line
organ in which neomycin competes with calcium ion for
membrane binding sites on the hair cells of the
acoustico-lateralis systems that activates the
transduction process (Sand, 1975 Yanagisawa et al.,
1977 Kroese and Van de Bercken, 1980 and Williams et
al, 1987). In chronic exposure, it causes degeneration
of the hair cells in the inner ear (Hawkins, 1976) and
reduction of responsiveness in touch corpuscles
(Baumann et al., 1986).
A local anesthetics like action as reported by
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Sokol l and Diecke (19 69) cannot be reproduced in here.
It is quite likely that neomycin behaves' differently
from the local anesthetics on the effect of the
blockade of sodium and potassium currents.
10 MM K2SO4 in Krebs solution shows a complete
blockade of the A potential in 5-10 minutes in the
present experimental arrangement. However, in the
unmyelinated nerve fibre, the blocking effect of the C
potential is slower and smaller than the myelineated
nerve fibre. It may be because the potassium and sodium
channel in the unmyelinated nerve fibre are surrounded
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